[go: up one dir, main page]

WO2019088258A1 - Photodegradable cell immobilization agent - Google Patents

Photodegradable cell immobilization agent Download PDF

Info

Publication number
WO2019088258A1
WO2019088258A1 PCT/JP2018/040853 JP2018040853W WO2019088258A1 WO 2019088258 A1 WO2019088258 A1 WO 2019088258A1 JP 2018040853 W JP2018040853 W JP 2018040853W WO 2019088258 A1 WO2019088258 A1 WO 2019088258A1
Authority
WO
WIPO (PCT)
Prior art keywords
cell
substrate
photodegradable
fixing agent
hydrophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2018/040853
Other languages
French (fr)
Japanese (ja)
Inventor
哲志 山口
岡本 晃充
ヤジェンブスカ・ナタリア・テレサ
森 泉田
真也 山平
長棟 輝行
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Original Assignee
University of Tokyo NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokyo NUC filed Critical University of Tokyo NUC
Priority to JP2019550500A priority Critical patent/JP7205910B2/en
Publication of WO2019088258A1 publication Critical patent/WO2019088258A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/332Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier

Definitions

  • the present invention relates to a photodegradable cell fixing agent excellent in cell immobilization power, a substrate for cell immobilization having a surface modified with the photolytic cell fixing agent, and a cell recovery method using the substrate .
  • Conventional cell separation / sorting techniques can be classified as in the following 1) to 5). 1) Method of centrifugation using differences in cell size and specific gravity 2) Method of fluorescently labeling cells and separation using a flow cytometer 3) Arraying cells using microwells and separation while observing Method 4) Method of fixing cells with a photolytic gel and dissolving and separating the gel by light irradiation while observing 5) Fixing cells by light irradiation while arranging cells using a photodegradable cell immobilization material Method of decomposing and separating
  • the method (1) is a simple cell separation method, there are problems such as low separation accuracy and unsuitable for selection of rare cells.
  • the method (2) is the most commonly used cell sorting method because of its high throughput, but it can not simultaneously observe differences between cells because it can not observe multiple cells simultaneously at the same time, and it can not follow changes over time. There is a problem called.
  • the method of (3) has recently attracted attention in that it can overcome the problems of the method of (2).
  • problems remain in the method of recovering arrayed cells. For example, in the method using a micromanipulator, the throughput is lowered because each cell is absorbed by a capillary (eg, Patent Document 1).
  • Other techniques for extracting cells electrochemically and physicochemically have been developed, but have the disadvantage that the cells are directly stressed.
  • the method (4) has recently attracted attention in that it is highly likely to overcome the separation speed, which is the problem of the method (3).
  • An aqueous solution containing cells is gelled using a photodegradable crosslinking agent, and the gel can be dissolved by light irradiation, and only desired cells can be recovered conveniently and rapidly (eg, Patent Document 2).
  • Patent Document 2 In order to immobilize individual cells without contacting them in the lateral direction and stacking them in the vertical direction, the cell density must be lowered, and the number of cells that can be observed and separated at one time is extremely small. There is a drawback.
  • the method (5) is advantageous in that the low cell density, which is the problem of the method (4), can be improved.
  • the present inventors arrange and fix cells in a microchannel with already photolyzable polyethylene glycol (PEG) lipid, and when the cells to be collected are subjected to light irradiation to apply flux, the cells It has been found that it is possible to selectively detach from the substrate (Non-patent Document 1).
  • the immobilizing power of the cells is low, and when one cell is separated, cells not irradiated with light are also detached by the shear stress of the microfluidic and can not be used for cell separation. There was a problem of that. Therefore, a strong cell immobilization power photolytic cell immobilization agent capable of sufficiently immobilizing single cells is essential for cell isolation.
  • the photocleavable cell fixing agent of Non-Patent Document 1 developed by the inventors until now is a compound in which polyethylene glycol (PEG) and a lipid are linked via a photocleavable linker, and this molecule is used as a substrate
  • PEG polyethylene glycol
  • the lipid moiety interacts with the lipid bilayer of cells, it is possible to immobilize any cells, whether adherent cells or non-adherent cells, on a substrate.
  • the spot size is reduced and cells are immobilized one by one, the flow rate required to release the cells allows 60 to 80% of the cells to be released in a few minutes without light irradiation. It will Then, this invention makes it a subject to develop the photodegradable cell fixing agent excellent in cell immobilization power, in order to compensate the fault of the conventional cell sorting method.
  • the present inventors have found that a specific length between the photocleavable site in the structure of the conventional photodegradable PEG lipid and the hydrophobic site that binds to the target cell is By inserting a hydrophilic region having a diameter, it is possible to strengthen the cell immobilization power, stably immobilize a substance covered with any cell or lipid membrane, and selectively recover it by light irradiation. It can be found that the present invention has been completed.
  • the present invention ⁇ 1> A photocleavable cell fixing agent for fixing a predetermined target cell on a substrate, the hydrophobic chain capable of interacting with the target cell, in the form of a monolayer on the surface of the substrate It has a hydrophilic chain that can be arranged, and a hydrophilic linker that links the hydrophobic chain and the hydrophilic chain, and a photodegradable linker, and the hydrophilic linker is between the hydrophobic chain and the photodegradable linker.
  • Said photodegradable cell fixing agent characterized in that it is arranged in ⁇ 2>
  • the photodegradable cell fixing agent according to ⁇ 1>, wherein the hydrophilic linker has the following partial structure; (Wherein, m is a natural number greater than 2)
  • the present invention provides: ⁇ 13> A substrate for cell immobilization, having a surface modified with the photolytic cell immobilization agent according to any one of ⁇ 1> to ⁇ 12>above; ⁇ 14> The substrate for cell immobilization according to ⁇ 13>, which has a patterned surface modification having a photolytic cell immobilization agent only in a specific surface area of the substrate; and ⁇ 15> A step of modifying the entire substrate surface with the photolytic cell fixing agent according to any one of the above ⁇ 1> to ⁇ 13>, and the surface modification with the photolytic cell fixing agent is maintained only in a specific region A step of patterning the surface, wherein light is irradiated to a region other than the specific region on the surface of the substrate to cut the photodegradable linker moiety in the photodegradable cell fixing agent,
  • the present invention provides a method for producing a cell immobilizing substrate comprising the
  • the invention provides: The process which makes the solution containing a predetermined
  • the present invention provides a method for recovering cells, which comprises the steps of: separating and recovering from a substrate for cell immobilization.
  • the cell immobilization power can be enhanced, so that target cells can be stably immobilized and selectively recovered by light irradiation.
  • the substrate for cell immobilization which has been surface-modified with the photolytic cell-fixing agent of the present invention can immobilize cells at a single cell level by patterning the surface modification region in advance by light irradiation, and a strong flow rate The cell pattern can be firmly maintained under
  • FIG. 1 is a schematic view showing the entire structure of the photodegradable cell fixing agent of the present invention.
  • FIG. 2 is a schematic view of a substrate surface-modified with the photolytic cell fixing agent of the present invention and a conceptual view of the immobilization / recovery of cells.
  • FIG. 3 is a schematic view showing a patterning step of surface modification in the substrate for cell immobilization of the present invention.
  • FIG. 4 is a graph showing the cell survival rate for the photolytic cell immobilization agent of the present invention and a comparative example.
  • FIG. 5 is a graph showing the light irradiation dependency of the cell survival rate by the photolytic cell fixing agent of the present invention.
  • FIG. 6 is an image of a 1-cell microarray formed on the substrate for cell immobilization of the present invention.
  • FIG. 6 (a) is a fluorescence image of an EGFP-expressing BaF3 cell array formed on a cell immobilization substrate coated with collagen as a covering layer.
  • FIG. 6 (a) is a bright field image of an EGFP-expressing BaF3 cell array formed on a cell immobilization substrate coated with BSA as a coating layer.
  • FIG. 7 is a fluorescence image before and after selective detachment of the cell array.
  • FIG. 8 is a graph showing the cell detachment rate in light-irradiated spots and non-irradiated spots.
  • FIG. 9 is an image of dendritic cells cultured on a substrate for cell immobilization.
  • the photodegradable cell fixing agent of the present invention is (A) a hydrophobic chain having a function of interacting with a target cell to bind to the cell, (B) hydrophilic chains which can be arranged in the form of a monomolecular film on the surface of a substrate, Furthermore, it has (c) a hydrophilic linker and (d) a photocleavable linker as two linker sites for linking these hydrophobic chains and hydrophilic chains. And, it is characterized in that the hydrophilic linker (c) is disposed between the hydrophobic chain (a) and the photodegradable linker (d).
  • the entire structure of the photolytic cell fixing agent of the present invention is a structure in which these (a) to (d) are linked in the following order.
  • the linkage of each site may be, for example, a covalent bond such as an amide bond, an ester bond, an ether bond, a thioether bond, a carbamate bond, a thiocarbamate bond, a triazole bond, or a urea bond.
  • the linkage between the photocleavable linker moiety (d) and the hydrophilic chain (b) is an amide bond or an ester bond from the viewpoint of permitting cleavage of the photodegradable linker moiety (d) by light irradiation. Is preferred.
  • FIG. 2 the schematic diagram of the base material surface-modified by the photolytic cell fixing agent of this invention, and the conceptual diagram of immobilization and collection
  • the photolytic cell fixing agent modifies the surface of the substrate by binding to the surface of the substrate directly at the end of the hydrophilic chain (b) or via a covering layer described later.
  • the photocleavable cell fixing agent is preferably arranged in the form of a monolayer on the surface of the substrate.
  • the hydrophobic chain (a) can bind to and capture a target cell by an interaction such as a hydrophobic interaction. Thereby, target cells can be immobilized on a specific region of the substrate surface. Thereafter, light irradiation is performed on a desired region on the substrate surface, whereby the target cells can be separated from the substrate surface and recovered by being decomposed with the photodegradable linker portion (d).
  • cells can include animal cells, plant cells, insect cells, prokaryotic cells, fungal cells and the like, and generally do not adhere to or extend on the surface of a carrier such as a culture device, but in a suspended or precipitated state
  • a carrier such as a culture device
  • proliferating cells eg, blood cells
  • adheres to or extends on the surface of the carrier are dispersed from the carrier with a suitable dispersing agent such as EDTA-trypsin, dispase, etc. and temporarily suspended.
  • a suitable dispersing agent such as EDTA-trypsin, dispase, etc.
  • organisms having a phospholipid bilayer membrane on the surface of liposomes, exosomes, bacteria, viruses, organelles, plant cells from which cell walls have been removed protoplasts
  • substances having lipids such as lipid-coated particles can also be immobilized.
  • the hydrophobic chain (a) is a site for interacting with a target cell and capturing the target cell.
  • noncovalent interaction such as hydrophobic interaction can be used.
  • the hydrophobic chain (a) can bind to a target cell by hydrophobic interaction with a lipid moiety in a cell membrane or the like which is a lipid bilayer membrane.
  • the hydrophobic chain (a) is not particularly limited as long as it can bind to a target cell by hydrophobic interaction, but it may be a saturated or unsaturated hydrocarbon chain which may have a substituent.
  • hydrocarbon chains include, for example, a C 7-30 alkyl group (preferably a C 7-22 alkyl group), a C 6-14 aryl group, and a C 6-14 aryl C 7-30 alkyl group (preferably C 6 C). 6-14 aryl C 7-22 alkyl group), and C 7-30 alkyl C 6-14 aryl group (preferably C 6-14 aryl C 7-22 alkyl group) and the like.
  • adjacent carbon atoms may be linked by a C 7-30 alkyl group which may be linked by 1 to 3 unsaturated bonds, and adjacent carbon atoms may be linked by 1 to 3 unsaturated bonds C 7-22 alkyl group, or C 11-22 alkyl group in which adjacent carbon atoms may be linked by 1 to 3 unsaturated bonds, or adjacent carbon atoms are linked by 1 to 3 unsaturated bonds It may be a C 16-18 alkyl group which may be linked.
  • the hydrophobic chain (a) is a hexadecyl group, a heptadecyl group, an octadecyl (stearyl) group, a cis-9-hexadecenyl (palmitolayl) group, a cis-8-heptadecenyl group, a trans-8-heptadecenyl group, a trans -9-octadecenyl (elaidyl) group, cis -9-octadecenyl (oleyl) group, cis, cis-9,12-octadecadienyl (linolenyl) group, (9E, 12E, 15E) -octadeca-9, 12, It can be a 15-trienyl (erilide linolenyl) group.
  • the oleyl group which is a part of the phospholipid which comprises
  • the hydrophilic chain (b) is preferably constituted by a hydrophilic polymer.
  • a hydrophilic polymer polysaccharides such as polyalkylene glycol, polyvinyl alcohol, polyacrylic acid, polypeptide, polyacrylamide and dextran, or polymers and copolymers of glycolic acid derivatives, lactic acid derivatives and p-dioxane derivatives Etc. can be used.
  • the polyalkylene glycol is preferably a polymer of an oxyalkylene unit having 2 to 4 carbon atoms, and one having an average polymerization number in the range of 2 to 500 (preferably 45 to 500) can be used.
  • the hydrophilic polymer is preferably a biocompatible polymer, more preferably polyethylene glycol (PEG).
  • the hydrophilic chain (b) may further have an optional substituent.
  • the hydrophilic chain (b) preferably has a functional group at its end for linking to the substrate surface by covalent bond or the like.
  • a terminal functional group for example, those shown below can be used (wherein, the arrow indicates the point of attachment to the hydrophilic chain (b)).
  • the terminal functional group may be an active ester group such as N-hydroxysuccinimide (NHS), a carboxyl group, a silanol group, a disulfide group or a thiol group.
  • an active ester group such as N-hydroxysuccinimide (NHS), a carboxyl group, a silanol group, a disulfide group or a thiol group.
  • NHS N-hydroxysuccinimide
  • the hydrophilic linker (c) is disposed between the hydrophobic chain (a) and the photocleavable linker (d) as described above. It is a feature of the present invention that by inserting a hydrophilic linker (c) having a predetermined length, target cells can be more firmly immobilized as compared with conventional methods.
  • the hydrophilic linker (c) is preferably constituted by a hydrophilic polymer.
  • hydrophilic chain (b) As the hydrophilic chain (b), as the hydrophilic polymer, polysaccharides such as the above polyalkylene glycol, polyvinyl alcohol, polyacrylic acid, polypeptide, polyacrylamide, dextran and the like, or glycolic acid derivatives and lactic acid derivatives, Polymers, copolymers and the like of p-dioxane derivatives can be used.
  • the polyalkylene glycol is preferably a polymer of an oxyalkylene unit having 2 to 4 carbon atoms, and one having an average polymerization number in the range of 2 to 100 (preferably 4 to 40) can be used.
  • the hydrophilic polymer is preferably a biocompatible polymer, more preferably polyethylene glycol (PEG).
  • the hydrophilic linker (c) preferably has the following partial structure having a repeating unit derived from ethylene glycol.
  • n is a natural number greater than 2, preferably a natural number of 3 to 100. More preferably, m is a natural number of 4 to 40.
  • hydrophilic chain (b) and the hydrophilic linker (c) are both composed of the same hydrophilic polymer.
  • the hydrophilic chain (b) and the hydrophilic linker (c) both contain polyethylene glycol.
  • the photocleavable linker (d) contains a functional group that can be decomposed by irradiation with light such as visible light and ultraviolet light.
  • target cells can be separated and collected from the surface of the substrate by performing light irradiation after capturing the target cells in the hydrophobic chain (a).
  • the hydrophobic chain (a) is detached in advance by irradiating a specific area with light, and a desired area is obtained. It is also possible to pattern so as to have cell binding property.
  • the functional group of the photodegradable linker (d) that can be decomposed by light irradiation is not particularly limited as long as it can cleave the hydrophilic linker (c) and the hydrophilic chain (b) by photoreaction, -A bivalent group having a -nitrobenzyl skeleton, a coumarin-4-ylmethyl skeleton, a phenylcarbonylmethyl skeleton or a 7-nitroindolinocarbonyl skeleton can be used.
  • it is bivalent having a 2-nitrobenzyl skeleton.
  • the compound has an oleyl group as the hydrophobic chain (a); a polyethylene glycol chain as the hydrophilic chain (b) and the hydrophilic linker (c); a 2-nitrobenzyl group in the photocleavable linker (d); And N-hydroxysuccinimide at the end of the hydrophilic chain (b) for binding to a substrate.
  • m is a natural number greater than 2, and n is a natural number of 50 or more.
  • m is preferably preferably a natural number of 3 to 100, more preferably m is a natural number of 4 to 8.
  • the present invention also relates to a cell immobilizing substrate having a surface modified with the above-mentioned photolyzable cell immobilizing agent.
  • the surface structure of the cell immobilizing substrate is, as described above, a photocleavable cell fixing agent bound to the surface of the substrate directly at the end of the hydrophilic chain (b) or via a covering layer described later. is there.
  • the photocleavable cell fixing agent is preferably arranged in the form of a monolayer on the surface of the substrate.
  • the material, shape, and the like of the base material to be modified by the photodegradable cell fixing agent are not particularly limited, and various suitable base materials can be selected according to the use and the like.
  • the carrier for example, particles such as beads
  • the carrier may be colloidal
  • fibrous structures for example, tubes, containers (eg test tubes and vials).
  • Materials of the substrate to be modified include glass; cement; ceramics or fine ceramics such as chinaware; polymer resins such as polyethylene terephthalate, cellulose acetate, polycarbonate, polystyrene and polymethyl methacrylate; biomaterials such as polypeptide and protein; silicon; Activated carbon; porous glass; porous ceramics; porous silicon; porous activated carbon; nonwoven fabric; filter paper; membrane filter; conductive material such as gold, etc. may be mentioned.
  • the surface of the substrate to be modified is coated with a polymer such as polycation or treated with a silane coupling agent having a substituent introduced onto the substrate surface. It may be applied, or reactive functional groups may be introduced by plasma treatment.
  • the photolytic cell fixing agent may be modified by direct bonding to the substrate surface, or a coating layer is provided on the substrate surface, and the photolytic cell fixing agent is applied to the surface of the coating layer. It is also possible to carry out surface modification by bonding.
  • a coating layer for example, collagen, bovine serum albumin (BSA), 3-aminopropyltriethoxysilane (APTES), or ovalbumin can be used.
  • the substrate for cell immobilization of the present invention can have a patterned surface modification having a photolytic cell fixing agent only on a specific surface area.
  • target cells can be immobilized on a specific area of the substrate surface.
  • a plurality of spot-type modified regions can be provided.
  • the diameter of the spot for immobilizing one cell depends on the size of the target cell, but can be approximately 2 to 30 ⁇ m, or 5 to 15 ⁇ m.
  • the substrate for cell immobilization having such a patterned surface modification can be prepared by the following steps as shown in FIG. (A) modifying the entire substrate surface with a photolytic cell fixing agent, and (B) patterning the surface such that the surface modification with the photolytic cell fixing agent is maintained only in a specific region And irradiating the region other than the specific region on the substrate surface with light to cleave the photocleavable linker moiety in the photocleavable cell fixing agent.
  • the present invention is also directed to a cell sorting technique in which target cells are immobilized and selectively recovered using a substrate for cell immobilization which has been surface-modified with a photolytic cell immobilization agent.
  • the cell recovery method of the present invention comprises the following steps: (1) contacting a solution containing predetermined target cells with a substrate for cell immobilization, and immobilizing the target cells on the substrate for cell immobilization, (2) The cell immobilization substrate is irradiated with light, and the photocleavable linker moiety in the photodegradable cell immobilization agent on the surface of the cell immobilization substrate is cut, whereby the immobilization is performed. Separating and recovering target cells from the cell immobilization substrate.
  • a base for cell immobilization can be placed in the microchannel as a place to perform the method.
  • a flux can be applied to the surface of the substrate to recover target cells after cleavage of the photocleavable linker moiety.
  • the reaction solution was added with MgSO 4 for drying, and after suction filtration to remove MgSO 4 , the solvent was removed under reduced pressure. After vacuum drying, an orange solid was obtained. Thereafter, the product is dissolved in vinegar and saturated by removal under reduced pressure, hexane is added dropwise until the drop in the dropping does not disappear, and the mixture is allowed to stand at -20 ° C, and the precipitated precipitate is collected by suction filtration three times repeatedly. , Recrystallized. At this time, a yellowish white paste-like solid was obtained in the first and second times, and an orange powder was obtained in the third time. The resulting solid was dried under vacuum to give compound 4. The identification was performed by 1 H-NMR (DMSO-d6) (FIG. 5-9), and the yield was 1.0992 g (1,2nd 0.95 g, 3rd 0.1492 g), and the yield was 76.4%.
  • Substrate preparation Surface modification of the glass substrate with the photodegradable cell fixing agent was performed in the following procedure.
  • Photolytic cell immobilization agent (PEG lipid) modification of substrate spot method
  • the PEG lipid to be used for modification was prepared by dissolving it in dry DMSO so as to be 10 mM, aliquoted in 5 ⁇ l aliquots, and stored at ⁇ 20 ° C. after Ar substitution.
  • This stock solution is diluted with 495 ⁇ l of PBS- to 100 ⁇ M immediately before use, and placed in a 4-well dish where 0.3 ⁇ l of total 0.3 ⁇ l spots are placed at 1 cm intervals in the center of the channel, and the incubator (37 ° C, Incubate for 1 hour in 5% CO 2 ), then wash 6 times with MQ and air dry.
  • eGFP expressing Ba / F3 RPMI (10% FBS), 1 ng / ml IL3 Passage Ba / F3 is only diluted in basic fresh medium. Frozen cells are collected in a 15 ml tube, washed once with a clean medium, suspended in Cell Banker, aliquoted in 0.5 or 1 ml aliquots, and stored at -80 ° C. Long term storage samples were stored in liquid nitrogen.
  • Photopatterning Photoirradiation was used with Asahi Spectrometer MAX-302, and a filter was used with LX0360 (360 nm ⁇ 2 nm). The light was automatically emitted using the MAX-302 timer function based on the amount of light measured by the light amount meter.
  • the surface of the mask of the photo mask faces up and the base of the substrate is modified with the PEG-modified surface facing down, with respect to light from below. Contact exposure was performed by putting.
  • the PEG lipid of the comparative example has the following structure and has a photocleavable linker between the hydrophobic chain and the hydrophilic chain, but the hydrophobic chain and the photocleavable linker are directly linked: It does not have a hydrophilic linker.
  • the photodegradable cell fixing agent of the present invention in which the cell immobilization power is enhanced by incorporating a hydrophilic linker, it is possible to selectively recover the cells immobilized one by one by light irradiation. Indicated.
  • the bottom surface of the microchannel is irradiated with a pattern of ultraviolet light (365 nm) of 3 J / cm 2 or more, and the surface on which cells are not immobilized
  • the region where the hydrophobic chain part of the degradable cell fixing agent was released and the surface (non-irradiated region) to be fixed were patterned.
  • the cell suspension is introduced into the microchannel, and the cells are immobilized through the interaction of the hydrophobic chain of the photolytic cell fixing agent in the non-irradiated area with the cells, and the cells are about 2 to 5 ml / min.
  • the cells non-specifically adsorbed to the light-irradiated area are washed out by rinsing by adjusting the flow rate to become Thereby, a cell array was produced in the microchannel.
  • FIG. 6 shows an image of the obtained 1-cell microarray.
  • FIG. 6 (a) is a fluorescence image of an EGFP-expressing BaF3 cell array formed on a cell immobilization substrate coated with collagen as a covering layer.
  • FIG. 6 (a) is a bright field image of an EGFP-expressing BaF3 cell array formed on a cell immobilization substrate coated with BSA as a coating layer.
  • the cell detachment rate in the light-irradiated spot and the non-irradiated spot calculated by analysis of the fluorescence image before and after light irradiation is shown in FIG. This result shows that cells can be selectively detached by light irradiation by using the substrate for cell immobilization of the present invention.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polyethers (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

[Problem] To develop a photodegradable cell immobilization agent having superior cell immobilization ability. [Solution] This photodegradable cell immobilization agent is for immobilizing a predetermined target cell onto a base material, the agent being characterized by comprising a hydrophobic chain capable of interacting with the target cell, a hydrophilic chain capable of being arrayed into a monomolecular film on a surface of the base material, and a hydrophilic linker and a photodegradable linker which link the hydrophobic chain and the hydrophilic chain together, wherein the hydrophilic linker is positioned between the hydrophobic chain and the photodegradable linker.

Description

光分解性細胞固定化剤Photodegradable cell fixing agent

 本発明は、細胞固定化力に優れた光分解性細胞固定化剤、当該光分解性細胞固定化剤により修飾した表面を有する細胞固定化用基材、及び当該基材を用いる細胞回収方法に関する。 The present invention relates to a photodegradable cell fixing agent excellent in cell immobilization power, a substrate for cell immobilization having a surface modified with the photolytic cell fixing agent, and a cell recovery method using the substrate .

 近年、細胞生物学の基礎研究から再生医療までの幅広い分野において、一細胞レベルで細胞を解析し、ハイスループットに選別する技術が求められている。例えば、血中の循環がん細胞(Circulating Tumor Cell; CTC)はその存在割合が非常に低いが、CTCを選別し解析することでがん化のメカニズムの解明や治療効果の評価などが可能になることが期待される。また、再生医療分野においては、ES細胞やiPS細胞を分化させて利用する際に、がん化するおそれのある未分化細胞を適切に除去する必要がある。さらに、抗体産生能の高いハイブリドーマを選択的に回収することは抗体医薬品を効率よく作製することに寄与する。このように、一細胞レベルでの細胞分離・選別技術は幅広い応用が期待され、その技術開発が求められている。 In recent years, in a wide range of fields from basic research in cell biology to regenerative medicine, a technology for analyzing cells at the single cell level and sorting them at high throughput is required. For example, circulating cancer cells (Circulating Tumor Cells; CTCs) in the blood have a very low proportion, but sorting and analysis of CTCs enables elucidation of the mechanism of canceration and evaluation of therapeutic effects, etc. Is expected to be In addition, in the regenerative medicine field, when differentiating and using ES cells and iPS cells, it is necessary to appropriately remove undifferentiated cells which may be transformed into cancer. Furthermore, selective recovery of hybridomas with high antibody production ability contributes to efficient production of antibody pharmaceuticals. Thus, the cell separation / sorting technology at the single cell level is expected to be applied in a wide range, and the development of the technology is required.

 従来の細胞分離・選別技術は、以下の1)~5)のように分類することができる。
1) 細胞のサイズ・比重の違いを利用して遠心分離する手法
2) 細胞を蛍光標識しフローサイトメーターを用いて分離する手法
3) マイクロウェルを用いて細胞をアレイ化し、観察しながら分離する手法
4) 光溶解性のゲルで細胞を固め、観察しながら光照射によってゲルを溶かして分離する手法
5) 光分解性の細胞固定化材料を用いて細胞を並べて、観察しながら光照射によって固定化材料を分解して分離する手法
Conventional cell separation / sorting techniques can be classified as in the following 1) to 5).
1) Method of centrifugation using differences in cell size and specific gravity 2) Method of fluorescently labeling cells and separation using a flow cytometer 3) Arraying cells using microwells and separation while observing Method 4) Method of fixing cells with a photolytic gel and dissolving and separating the gel by light irradiation while observing 5) Fixing cells by light irradiation while arranging cells using a photodegradable cell immobilization material Method of decomposing and separating

 しかしながら、上記(1)の手法は、単純な細胞の分離方法であるが、分離精度の低さや希少な細胞の選別には不向きといった問題点がある。(2)の手法はスループット性の高さゆえに最も良く用いられる細胞選別方法であるが、多くの細胞を同時に複数観察できないために細胞間の差異を同時に検出できない点や経時変化を追うことができないという課題がある。(3)の手法は、(2)の手法の課題を克服できる点で近年注目を集めているが、しかしながら、アレイ化された細胞の回収方法に課題が残る。例えば、マイクロマニピュレーターを用いる方法では、一細胞毎にキャピラリーで吸い上げるためにスループット性が落ちる(特許文献1など)。他にも電気化学・物理化学的に細胞を取り出す技術が開発されているが、細胞に直接的にストレスがかかってしまうという欠点がある。 However, although the method (1) is a simple cell separation method, there are problems such as low separation accuracy and unsuitable for selection of rare cells. The method (2) is the most commonly used cell sorting method because of its high throughput, but it can not simultaneously observe differences between cells because it can not observe multiple cells simultaneously at the same time, and it can not follow changes over time. There is a problem called. The method of (3) has recently attracted attention in that it can overcome the problems of the method of (2). However, problems remain in the method of recovering arrayed cells. For example, in the method using a micromanipulator, the throughput is lowered because each cell is absorbed by a capillary (eg, Patent Document 1). Other techniques for extracting cells electrochemically and physicochemically have been developed, but have the disadvantage that the cells are directly stressed.

 また、(4)の手法は、(3)の方法の課題である分離速度を克服できる可能性が高い点で近年注目を集めている。光分解性の架橋剤を用いて細胞を含む水溶液をゲル化し、光照射によってゲルを溶かして望みの細胞のみを簡便迅速に回収できる(特許文献2など)。しかし、個々の細胞を横方向に接触させず、上下方向に重ねずに固定化するには、細胞密度を下げざるを得ず、観察と分離を一度に行える細胞数が極めて少なくなってしまうという欠点がある。 In addition, the method (4) has recently attracted attention in that it is highly likely to overcome the separation speed, which is the problem of the method (3). An aqueous solution containing cells is gelled using a photodegradable crosslinking agent, and the gel can be dissolved by light irradiation, and only desired cells can be recovered conveniently and rapidly (eg, Patent Document 2). However, in order to immobilize individual cells without contacting them in the lateral direction and stacking them in the vertical direction, the cell density must be lowered, and the number of cells that can be observed and separated at one time is extremely small. There is a drawback.

 これに対し、(5)の手法は、(4)の方法の課題である低い細胞密度を改善できる点で優位性がある。例えば、本願発明者らは、既に光分解性のポリエチレングリコール(PEG)脂質を用いてマイクロ流路内に細胞を並べて固定し、回収したい細胞に光照射を施して流束をかけると、細胞が基板から選択的に脱離できることを見出している(非特許文献1)。しかし、かかる方法においても、細胞の固定化力が低く、1細胞ずつを離して並べると、光を照射していない細胞もマイクロ流体のせん断応力によって脱離してしまい、細胞の分離には使えないという問題点があった。従って、単一細胞を十分に固定化できるような強い細胞固定化力の光分解性細胞固定化剤が、細胞の単離には必要不可欠である。 On the other hand, the method (5) is advantageous in that the low cell density, which is the problem of the method (4), can be improved. For example, the present inventors arrange and fix cells in a microchannel with already photolyzable polyethylene glycol (PEG) lipid, and when the cells to be collected are subjected to light irradiation to apply flux, the cells It has been found that it is possible to selectively detach from the substrate (Non-patent Document 1). However, even in such a method, the immobilizing power of the cells is low, and when one cell is separated, cells not irradiated with light are also detached by the shear stress of the microfluidic and can not be used for cell separation. There was a problem of that. Therefore, a strong cell immobilization power photolytic cell immobilization agent capable of sufficiently immobilizing single cells is essential for cell isolation.

特開2010-14438号公報JP, 2010-14438, A 特開2014-226089号公報JP 2014-226089 A

S. Yamaguchi, et al, Angew. Chem. Int. Ed. 2012, 51, 128-131S. Yamaguchi, et al, Angew. Chem. Int. Ed. 2012, 51, 128-131

 これまでに発明者らが開発した非特許文献1の光分解性の細胞固定化剤は、光分解性リンカーを介してポリエチレングリコール(PEG)と脂質とをつないだ化合物であり、この分子を基板に修飾すると、脂質部分が細胞の脂質二分子膜と相互作用するため、接着細胞、非接着細胞を問わず任意の細胞を基板に固定化できるものである。しかし、スポットを小さくして、1細胞ずつ細胞を固定化した場合には、細胞を遊離させるのに必要な流速では、光を照射しなくても60~80%の細胞が数分で遊離してしまう。そこで、本発明は、従来の細胞選別法の欠点を補うために、細胞固定化力に優れた光分解性細胞固定化剤を開発することを課題とするものである。 The photocleavable cell fixing agent of Non-Patent Document 1 developed by the inventors until now is a compound in which polyethylene glycol (PEG) and a lipid are linked via a photocleavable linker, and this molecule is used as a substrate In this case, since the lipid moiety interacts with the lipid bilayer of cells, it is possible to immobilize any cells, whether adherent cells or non-adherent cells, on a substrate. However, if the spot size is reduced and cells are immobilized one by one, the flow rate required to release the cells allows 60 to 80% of the cells to be released in a few minutes without light irradiation. It will Then, this invention makes it a subject to develop the photodegradable cell fixing agent excellent in cell immobilization power, in order to compensate the fault of the conventional cell sorting method.

 本発明者は、上記課題を解決するべく鋭意検討を行った結果、従来の光分解性PEG脂質の構造における光分解性部位と、標的細胞と結合する疎水性部位との間に、特定の長さを有する親水性領域を挿入することで、細胞固定化力を強化することができ、任意の細胞や脂質膜で覆われた物質を安定的に固定化し、かつ光照射によって選択的に回収することができることを見出し、本発明を完成するに至ったものである。 As a result of intensive studies to solve the above problems, the present inventors have found that a specific length between the photocleavable site in the structure of the conventional photodegradable PEG lipid and the hydrophobic site that binds to the target cell is By inserting a hydrophilic region having a diameter, it is possible to strengthen the cell immobilization power, stably immobilize a substance covered with any cell or lipid membrane, and selectively recover it by light irradiation. It can be found that the present invention has been completed.

 すなわち、本発明は、一態様において、
<1>所定の標的細胞を基材上に固定するための光分解性細胞固定化剤であって、前記標的細胞と相互作用し得る疎水性鎖、前記基材の表面に単分子膜状に配列し得る親水性鎖、及び前記疎水性鎖と親水性鎖を連結する親水性リンカー及び光分解性リンカーを有し、前記親水性リンカーが、前記疎水性鎖と前記光分解性リンカーとの間に配置されていることを特徴とする該光分解性細胞固定化剤;
<2>前記親水性リンカーが、親水性ポリマーを含む、上記<1>に記載の光分解性細胞固定化剤;
<3>前記親水性リンカーが、ポリアルキレングリコールを含む、上記<1>に記載の光分解性細胞固定化剤;
<4>前記親水性リンカーが、以下の部分構造を有する、上記<1>に記載の光分解性細胞固定化剤;

Figure JPOXMLDOC01-appb-C000003
(式中、mは、2より大きい自然数である。)
<5>nが、4~40の自然数である、上記<4>に記載の光分解性細胞固定化剤;
<6>前記疎水性鎖が、置換基を有していてもよい飽和又は不飽和の炭化水素鎖である、上記<1>~<5>のいずれかに記載の光分解性細胞固定化剤;
<7>前記親水性鎖が、親水性ポリマーを含む、上記<1>~<6>のいずれかに記載の光分解性細胞固定化剤;
<8>前記親水性鎖が、ポリアルキレングリコールを含む、上記<1>~<6>のいずれかに記載の光分解性細胞固定化剤;
<9>前記光分解性リンカーが、2-ニトロベンジル骨格、クマリン-4-イルメチル骨格、フェニルカルボニルメチル骨格又は7-ニトロインドリノカルボニル骨格を有する二価の基である、上記<1>~<8>のいずれかに記載の光分解性細胞固定化剤;
<10>前記親水性鎖及び親水性リンカーがいずれも、ポリエチレングリコールを含む、上記<1>~<9>のいずれかに記載の光分解性細胞固定化剤;
<11>前記親水性鎖の末端に、前記基材の表面と共有結合により結合し得る置換基を有する、上記<1>~<10>のいずれかに記載の光分解性細胞固定化剤;及び
<12>以下の構造を有する、上記<1>に記載の光分解性細胞固定化剤
Figure JPOXMLDOC01-appb-C000004
(式中、mは、2~40の自然数であり、nは、45~500の自然数である。)
を提供するものである。 That is, in one aspect, the present invention
<1> A photocleavable cell fixing agent for fixing a predetermined target cell on a substrate, the hydrophobic chain capable of interacting with the target cell, in the form of a monolayer on the surface of the substrate It has a hydrophilic chain that can be arranged, and a hydrophilic linker that links the hydrophobic chain and the hydrophilic chain, and a photodegradable linker, and the hydrophilic linker is between the hydrophobic chain and the photodegradable linker. Said photodegradable cell fixing agent characterized in that it is arranged in
<2> The photodegradable cell fixing agent according to <1>, wherein the hydrophilic linker comprises a hydrophilic polymer;
<3> The photodegradable cell fixing agent according to <1>, wherein the hydrophilic linker comprises a polyalkylene glycol;
<4> The photodegradable cell fixing agent according to <1>, wherein the hydrophilic linker has the following partial structure;
Figure JPOXMLDOC01-appb-C000003
(Wherein, m is a natural number greater than 2)
The photolyzable cell fixing agent according to the above <4>, wherein <5> n is a natural number of 4 to 40;
<6> The photodegradable cell fixing agent according to any one of <1> to <5>, wherein the hydrophobic chain is a saturated or unsaturated hydrocarbon chain which may have a substituent. ;
<7> The photodegradable cell fixing agent according to any one of the above <1> to <6>, wherein the hydrophilic chain comprises a hydrophilic polymer;
<8> The photodegradable cell fixing agent according to any one of the above <1> to <6>, wherein the hydrophilic chain comprises a polyalkylene glycol;
<9> The above <1> to <10, wherein the photocleavable linker is a divalent group having a 2-nitrobenzyl skeleton, a coumarin-4-ylmethyl skeleton, a phenylcarbonylmethyl skeleton or a 7-nitroindolinoxycarbonyl skeleton. The photolyzable cell fixing agent according to any one of 8>;
<10> The photodegradable cell fixing agent according to any one of the above <1> to <9>, wherein the hydrophilic chain and the hydrophilic linker each contain polyethylene glycol;
<11> The photodegradable cell fixing agent according to any one of the above <1> to <10>, having a substituent which can be covalently bonded to the surface of the substrate at the end of the hydrophilic chain; And the photodegradable cell fixing agent according to <1>, having a structure of <12> or less
Figure JPOXMLDOC01-appb-C000004
(Wherein, m is a natural number of 2 to 40, and n is a natural number of 45 to 500)
To provide

また、別の態様において、本発明は、
<13>上記<1>~<12>のいずれかに記載の光分解性細胞固定化剤によって修飾された表面を有する、細胞固定化用基材;
<14>前記基材の特定の表面領域のみに光分解性細胞固定化剤を有する、パターン化された表面修飾を有する、上記<13>に記載の細胞固定化用基材;及び
<15>上記<1>~<13>のいずれかに記載の光分解性細胞固定化剤で基材表面全体を修飾する工程、及び光分解性細胞固定化剤による表面修飾が特定の領域のみ維持されるように表面をパターン化する工程であって、基材表面における前記特定の領域以外の領域に光を照射して、光分解性細胞固定化剤における光分解性リンカー部分を切断する、該工程、を含む細胞固定化用基材の製造方法
を提供するものである。
In another aspect, the present invention provides:
<13> A substrate for cell immobilization, having a surface modified with the photolytic cell immobilization agent according to any one of <1> to <12>above;
<14> The substrate for cell immobilization according to <13>, which has a patterned surface modification having a photolytic cell immobilization agent only in a specific surface area of the substrate; and <15> A step of modifying the entire substrate surface with the photolytic cell fixing agent according to any one of the above <1> to <13>, and the surface modification with the photolytic cell fixing agent is maintained only in a specific region A step of patterning the surface, wherein light is irradiated to a region other than the specific region on the surface of the substrate to cut the photodegradable linker moiety in the photodegradable cell fixing agent, The present invention provides a method for producing a cell immobilizing substrate comprising the

 さらに、別の態様において、本発明は、
<16>上記<13>又は<14>に記載の細胞固定化用基材に所定の標的細胞を含む溶液を接触させ、前記細胞固定化用基材に前記標的細胞を固定化する工程、前記細胞固定化用基材に光を照射し、前記細胞固定化用基材の表面の光分解性細胞固定化剤における光分解性リンカー部分を切断することで、前記固定化された標的細胞を前記細胞固定化用基材から分離・回収する工程、を含む、細胞の回収方法
を提供するものである。
In yet another aspect, the invention provides:
The process which makes the solution containing a predetermined | prescribed target cell contact the base material for cell immobilization as described in <16> said <13> or <14>, and immobilizes the said target cell on the said base material for cell immobilization, the said The substrate for cell immobilization is irradiated with light, and the photocleavable linker moiety in the photolyzable cell immobilization agent on the surface of the substrate for cell immobilization is cleaved, whereby the immobilized target cells are isolated. The present invention provides a method for recovering cells, which comprises the steps of: separating and recovering from a substrate for cell immobilization.

 本発明の光分解性細胞固定化剤によれば、細胞固定化力を強化することができるため、標的細胞を安定的に固定化し、かつ光照射によって選択的に回収することができる。また、本発明の光分解性細胞固定化剤で表面修飾した細胞固定化用基材は、光照射により表面修飾領域を予めパターン化することにより、1細胞レベルで細胞を固定化でき、強い流速下でも強固に細胞パターンを維持できる。 According to the photodegradable cell immobilization agent of the present invention, the cell immobilization power can be enhanced, so that target cells can be stably immobilized and selectively recovered by light irradiation. In addition, the substrate for cell immobilization which has been surface-modified with the photolytic cell-fixing agent of the present invention can immobilize cells at a single cell level by patterning the surface modification region in advance by light irradiation, and a strong flow rate The cell pattern can be firmly maintained under

図1は、本発明の光分解性細胞固定化剤の全体構造を示す模式図である。FIG. 1 is a schematic view showing the entire structure of the photodegradable cell fixing agent of the present invention. 図2は、本発明の光分解性細胞固定化剤により表面修飾した基材の模式図及び細胞の固定化・回収の概念図である。FIG. 2 is a schematic view of a substrate surface-modified with the photolytic cell fixing agent of the present invention and a conceptual view of the immobilization / recovery of cells. 図3は、本発明の細胞固定化用基材における表面修飾のパターン化工程を示す模式図である。FIG. 3 is a schematic view showing a patterning step of surface modification in the substrate for cell immobilization of the present invention. 図4は、本発明の光分解性細胞固定化剤及び比較例についての細胞残存率を示すグラフである。FIG. 4 is a graph showing the cell survival rate for the photolytic cell immobilization agent of the present invention and a comparative example. 図5は、本発明の光分解性細胞固定化剤による細胞残存率の光照射依存性を示すグラフである。FIG. 5 is a graph showing the light irradiation dependency of the cell survival rate by the photolytic cell fixing agent of the present invention. 図6は、本発明の細胞固定化用基材上に形成された1細胞マイクロアレイのイメージ画像である。図6(a)は、被覆層としてコラーゲンコーティングを行った細胞固定化用基材上に形成されたEGFP発現BaF3細胞アレイの蛍光画像である。図6(a)は、被覆層としてBSAコーティングを行った細胞固定化用基材上に形成されたEGFP発現BaF3細胞アレイの明視野像である。FIG. 6 is an image of a 1-cell microarray formed on the substrate for cell immobilization of the present invention. FIG. 6 (a) is a fluorescence image of an EGFP-expressing BaF3 cell array formed on a cell immobilization substrate coated with collagen as a covering layer. FIG. 6 (a) is a bright field image of an EGFP-expressing BaF3 cell array formed on a cell immobilization substrate coated with BSA as a coating layer. 図7は、細胞アレイの選択的脱離前後の蛍光画像である。FIG. 7 is a fluorescence image before and after selective detachment of the cell array. 図8は、光照射スポット及び非照射スポットにおける細胞脱離率を示すグラフである。FIG. 8 is a graph showing the cell detachment rate in light-irradiated spots and non-irradiated spots. 図9は、細胞固定化用基材上で培養した樹状細胞のイメージ画像である。FIG. 9 is an image of dendritic cells cultured on a substrate for cell immobilization.

 以下、本発明の実施形態について説明する。本発明の範囲はこれらの説明に拘束されることはなく、以下の例示以外についても、本発明の趣旨を損なわない範囲で適宜変更し実施することができる。 Hereinafter, embodiments of the present invention will be described. The scope of the present invention is not restricted by these explanations, and it can be suitably changed and implemented in the range which does not spoil the meaning of the present invention also except the following examples.

1.光分解性細胞固定化剤
 本発明の光分解性細胞固定化剤は、
(a)標的細胞と相互作用して当該細胞と結合する機能を有する疎水性鎖、
(b)基材の表面に単分子膜状に配列し得る親水性鎖、
を有し、さらに、これら疎水性鎖と親水性鎖を連結するための2つのリンカー部位として
(c)親水性リンカー、及び
(d)光分解性リンカー
を有する。そして、親水性リンカー(c)が、疎水性鎖(a)と光分解性リンカー(d)との間に配置されていることを特徴とする。
1. Photodegradable Cell Fixing Agent The photodegradable cell fixing agent of the present invention is
(A) a hydrophobic chain having a function of interacting with a target cell to bind to the cell,
(B) hydrophilic chains which can be arranged in the form of a monomolecular film on the surface of a substrate,
Furthermore, it has (c) a hydrophilic linker and (d) a photocleavable linker as two linker sites for linking these hydrophobic chains and hydrophilic chains. And, it is characterized in that the hydrophilic linker (c) is disposed between the hydrophobic chain (a) and the photodegradable linker (d).

 したがって、図1に示すように、本発明の光分解性細胞固定化剤の全体構造は、これら(a)~(d)を以下の順で連結した構造となる。各部位の連結は、例えば、アミド結合やエステル結合、エーテル結合、チオエーテル結合、カルバメート結合、チオカルバメート結合、トリアゾール結合、尿素結合等の共有結合を用いることができる。なお、光分解性リンカー部分(d)と親水性鎖(b)との間の連結は、光照射による光分解性リンカー部分(d)の切断を許容するという観点からは、アミド結合又はエステル結合が好ましい。

Figure JPOXMLDOC01-appb-C000005
Therefore, as shown in FIG. 1, the entire structure of the photolytic cell fixing agent of the present invention is a structure in which these (a) to (d) are linked in the following order. The linkage of each site may be, for example, a covalent bond such as an amide bond, an ester bond, an ether bond, a thioether bond, a carbamate bond, a thiocarbamate bond, a triazole bond, or a urea bond. The linkage between the photocleavable linker moiety (d) and the hydrophilic chain (b) is an amide bond or an ester bond from the viewpoint of permitting cleavage of the photodegradable linker moiety (d) by light irradiation. Is preferred.
Figure JPOXMLDOC01-appb-C000005

 図2に、本発明の光分解性細胞固定化剤により表面修飾した基材の模式図、及び細胞の固定化・回収の概念図を示す。光分解性細胞固定化剤は、親水性鎖(b)の末端で基材表面に直接或いは後述の被覆層を介して結合することで、基材表面を修飾している。光分解性細胞固定化剤は、好ましくは、基材の表面に単分子膜状に配列される。一方、疏水性鎖(a)は、疎水性相互作用等の相互作用によって標的細胞と結合・捕捉することができる。これにより、基材表面の特定領域に標的細胞を固定化することができる。その後、基材表面における所望の領域に光照射を行うことにより、光分解性リンカー部分(d)で分解することで、標的細胞を基材表面から分離し、回収することができる。 In FIG. 2, the schematic diagram of the base material surface-modified by the photolytic cell fixing agent of this invention, and the conceptual diagram of immobilization and collection | recovery of a cell are shown. The photolytic cell fixing agent modifies the surface of the substrate by binding to the surface of the substrate directly at the end of the hydrophilic chain (b) or via a covering layer described later. The photocleavable cell fixing agent is preferably arranged in the form of a monolayer on the surface of the substrate. On the other hand, the hydrophobic chain (a) can bind to and capture a target cell by an interaction such as a hydrophobic interaction. Thereby, target cells can be immobilized on a specific region of the substrate surface. Thereafter, light irradiation is performed on a desired region on the substrate surface, whereby the target cells can be separated from the substrate surface and recovered by being decomposed with the photodegradable linker portion (d).

 ここで、「細胞」には、動物細胞、植物細胞、昆虫細胞、原核細胞、真菌細胞などを含むことができ、一般に培養器具等の担体表面に接着・伸展せず、懸濁または沈殿状態で増殖する「浮遊細胞」と呼ばれるもの(例えば血球細胞)や、担体表面に接着・伸展する「接着細胞」をEDTA-トリプシン、ディスパーゼ等の適当な分散剤で担体から分散させ、一時的に浮遊させたもの(例えばEDTA液で担体から剥離した線維芽細胞)、および担体に接着した状態の細胞を含む。また、リポソーム、エキソソーム、細菌、ウィルス、オルガネラ、細胞壁を除去した植物細胞(プロトプラスト)等の表面にリン脂質二重膜を有する生命体も含まれる。また、本発明の光分解性細胞固定化剤によれば、これら以外にも、脂質コート粒子など脂質を有する物質を固定化することもできる。 Here, "cells" can include animal cells, plant cells, insect cells, prokaryotic cells, fungal cells and the like, and generally do not adhere to or extend on the surface of a carrier such as a culture device, but in a suspended or precipitated state What is referred to as proliferating "suspended cells" (eg, blood cells) or "adhered cells" that adheres to or extends on the surface of the carrier are dispersed from the carrier with a suitable dispersing agent such as EDTA-trypsin, dispase, etc. and temporarily suspended. (Eg, fibroblasts detached from carrier by EDTA solution), and cells in a state of being adhered to carrier. Also included are organisms having a phospholipid bilayer membrane on the surface of liposomes, exosomes, bacteria, viruses, organelles, plant cells from which cell walls have been removed (protoplasts) and the like. Moreover, according to the photodegradable cell immobilization agent of the present invention, in addition to these, substances having lipids such as lipid-coated particles can also be immobilized.

 疎水性鎖(a)は、標的細胞と相互作用により結合し、当該標的細胞を捕捉するための部位である。かかる相互作用としては、疎水性相互作用等の非共有結合的な相互作用を用いることができる。具体的には、疎水性鎖(a)は、脂質二分子膜である細胞膜等における脂質部分との疎水性相互作用によって標的細胞と結合することができる。 The hydrophobic chain (a) is a site for interacting with a target cell and capturing the target cell. As such interaction, noncovalent interaction such as hydrophobic interaction can be used. Specifically, the hydrophobic chain (a) can bind to a target cell by hydrophobic interaction with a lipid moiety in a cell membrane or the like which is a lipid bilayer membrane.

 疎水性鎖(a)は、疎水性相互作用により標的細胞に結合できるものである限り特に限定されないが、置換基を有していてもよい飽和又は不飽和の炭化水素鎖であることができる。かかる炭化水素鎖の例示としては、例えば、C7-30アルキル基(好ましくはC7-22アルキル基)、C6-14アリール基、C6-14アリールC7-30アルキル基(好ましくはC6-14アリールC7-22アルキル基)、及びC7-30アルキルC6-14アリール基(好ましくはC6-14アリールC7-22アルキル基)などが挙げられる。好ましくは、隣接する炭素原子が1~3個の不飽和結合によって連結されていてもよいC7-30アルキル基、隣接する炭素原子が1~3個の不飽和結合によって連結されていてもよいC7-22アルキル基、又は隣接する炭素原子が1~3個の不飽和結合によって連結されていてもよいC11-22アルキル基、又は隣接する炭素原子が1~3個の不飽和結合によって連結されていてもよいC16-18アルキル基であることができる。より好ましくは、疎水性鎖(a)は、ヘキサデシル基、ヘプタデシル基、オクタデシル(ステアリル)基、シス-9-ヘキサデセニル(パルミトレイル)基、シス-8-ヘプタデセニル基、トランス-8-ヘプタデセニル基、トランス-9-オクタデセニル(エライジル)基、シス-9-オクタデセニル(オレイル)基、シス,シス-9,12-オクタデカジエニル(リノレニル)基、(9E,12E,15E)-オクタデカ-9,12,15-トリエニル(エライドリノレニル)基であることができる。特に、細胞膜を構成するリン脂質の一部であるオレイル基が好ましい。さらに、これらの疎水性鎖は、任意の置換基で置換されていてもよく、またN、S、O等のヘテロ原子を含んでもよい。 The hydrophobic chain (a) is not particularly limited as long as it can bind to a target cell by hydrophobic interaction, but it may be a saturated or unsaturated hydrocarbon chain which may have a substituent. Examples of such hydrocarbon chains include, for example, a C 7-30 alkyl group (preferably a C 7-22 alkyl group), a C 6-14 aryl group, and a C 6-14 aryl C 7-30 alkyl group (preferably C 6 C). 6-14 aryl C 7-22 alkyl group), and C 7-30 alkyl C 6-14 aryl group (preferably C 6-14 aryl C 7-22 alkyl group) and the like. Preferably, adjacent carbon atoms may be linked by a C 7-30 alkyl group which may be linked by 1 to 3 unsaturated bonds, and adjacent carbon atoms may be linked by 1 to 3 unsaturated bonds C 7-22 alkyl group, or C 11-22 alkyl group in which adjacent carbon atoms may be linked by 1 to 3 unsaturated bonds, or adjacent carbon atoms are linked by 1 to 3 unsaturated bonds It may be a C 16-18 alkyl group which may be linked. More preferably, the hydrophobic chain (a) is a hexadecyl group, a heptadecyl group, an octadecyl (stearyl) group, a cis-9-hexadecenyl (palmitolayl) group, a cis-8-heptadecenyl group, a trans-8-heptadecenyl group, a trans -9-octadecenyl (elaidyl) group, cis -9-octadecenyl (oleyl) group, cis, cis-9,12-octadecadienyl (linolenyl) group, (9E, 12E, 15E) -octadeca-9, 12, It can be a 15-trienyl (erilide linolenyl) group. In particular, the oleyl group which is a part of the phospholipid which comprises a cell membrane is preferable. Furthermore, these hydrophobic chains may be substituted with any substituent, and may contain heteroatoms such as N, S, O and the like.

 親水性鎖(b)は、好ましくは、親水性ポリマーにより構成される。かかる親水性ポリマーとしては、ポリアルキレングリコール、ポリビニルアルコール、ポリアクリル酸、ポリペプチド、ポリアクリルアミド、およびデキストラン等の多糖類、あるいはグリコール酸誘導体や乳酸誘導体、p-ジオキサン誘導体の重合体や共重合体等を用いることができる。ポリアルキレングリコールとしては、好ましくは炭素数2~4のオキシアルキレン単位の重合体であり、その平均重合数が2~500(好ましくは、45~500)の範囲であるものを用いることができる。当該親水性ポリマーは、生体適合性のポリマーであることが好ましく、ポリエチレングリコール(PEG)であることがより好ましい。親水性鎖(b)は、さらに任意の置換基を有していてもよい。 The hydrophilic chain (b) is preferably constituted by a hydrophilic polymer. As such a hydrophilic polymer, polysaccharides such as polyalkylene glycol, polyvinyl alcohol, polyacrylic acid, polypeptide, polyacrylamide and dextran, or polymers and copolymers of glycolic acid derivatives, lactic acid derivatives and p-dioxane derivatives Etc. can be used. The polyalkylene glycol is preferably a polymer of an oxyalkylene unit having 2 to 4 carbon atoms, and one having an average polymerization number in the range of 2 to 500 (preferably 45 to 500) can be used. The hydrophilic polymer is preferably a biocompatible polymer, more preferably polyethylene glycol (PEG). The hydrophilic chain (b) may further have an optional substituent.

 親水性鎖(b)は、上述のように、共有結合等により基材表面に連結するための官能基をその末端に有することが好ましい。そのような末端の官能基としては、例えば、以下に示すものを用いることができる(式中、矢印は親水性鎖(b)への結合点を表している)。

Figure JPOXMLDOC01-appb-C000006
As described above, the hydrophilic chain (b) preferably has a functional group at its end for linking to the substrate surface by covalent bond or the like. As such a terminal functional group, for example, those shown below can be used (wherein, the arrow indicates the point of attachment to the hydrophilic chain (b)).
Figure JPOXMLDOC01-appb-C000006

 好ましくは、末端の官能基は、N-ヒドロキシスクシンイミド(NHS)等の活性エステル基、カルボキシル基、シラノール基、ジスルフィド基、又はチオール基を用いることができる。後述のように、基材表面にコラーゲン等の被覆層を用いる場合には、これら被覆層と結合し得る官能基を用いることができ、例えば、コラーゲン被覆層の場合には、コラーゲン中のアミノ基と共有結合し得る活性エステル基が好ましく、特にNHS基を有することが好ましい。 Preferably, the terminal functional group may be an active ester group such as N-hydroxysuccinimide (NHS), a carboxyl group, a silanol group, a disulfide group or a thiol group. As described later, when a coating layer such as collagen is used on the substrate surface, a functional group capable of binding to the coating layer can be used. For example, in the case of a collagen coating layer, an amino group in collagen Preferred is an active ester group which can be covalently bonded to, particularly preferably having an NHS group.

 親水性リンカー(c)は、上述のように、疎水性鎖(a)と光分解性リンカー(d)との間に配置される。所定の長さを有する親水性リンカー(c)を挿入することにより、従来の手法と比べて、標的細胞をより強固に固定化し得ることが本発明の特徴である。親水性リンカー(c)は、好ましくは、親水性ポリマーにより構成される。親水性鎖(b)と同様に、かかる親水性ポリマーとしては、上記ポリアルキレングリコール、ポリビニルアルコール、ポリアクリル酸、ポリペプチド、ポリアクリルアミド、およびデキストラン等の多糖類、あるいはグリコール酸誘導体や乳酸誘導体、p-ジオキサン誘導体の重合体や共重合体等を用いることができる。ポリアルキレングリコールとしては、好ましくは炭素数2~4のオキシアルキレン単位の重合体であり、その平均重合数が2~100(好ましくは4~40)の範囲であるものを用いることができる。当該親水性ポリマーは、生体適合性のポリマーであることが好ましく、ポリエチレングリコール(PEG)であることがより好ましい。 The hydrophilic linker (c) is disposed between the hydrophobic chain (a) and the photocleavable linker (d) as described above. It is a feature of the present invention that by inserting a hydrophilic linker (c) having a predetermined length, target cells can be more firmly immobilized as compared with conventional methods. The hydrophilic linker (c) is preferably constituted by a hydrophilic polymer. As the hydrophilic chain (b), as the hydrophilic polymer, polysaccharides such as the above polyalkylene glycol, polyvinyl alcohol, polyacrylic acid, polypeptide, polyacrylamide, dextran and the like, or glycolic acid derivatives and lactic acid derivatives, Polymers, copolymers and the like of p-dioxane derivatives can be used. The polyalkylene glycol is preferably a polymer of an oxyalkylene unit having 2 to 4 carbon atoms, and one having an average polymerization number in the range of 2 to 100 (preferably 4 to 40) can be used. The hydrophilic polymer is preferably a biocompatible polymer, more preferably polyethylene glycol (PEG).

 より具体的には、親水性リンカー(c)は、エチレングリコール由来の繰り返し単位を有する、以下の部分構造を有することが好ましい。

Figure JPOXMLDOC01-appb-C000007
More specifically, the hydrophilic linker (c) preferably has the following partial structure having a repeating unit derived from ethylene glycol.
Figure JPOXMLDOC01-appb-C000007

 ここで、mは、2より大きい自然数であり、好ましくは、3~100の自然数である。より好ましくは、mは、4~40の自然数である。 Here, m is a natural number greater than 2, preferably a natural number of 3 to 100. More preferably, m is a natural number of 4 to 40.

 また、また、親水性鎖(b)と親水性リンカー(c)がいずれも、同一の親水性ポリマーで構成されることが好ましい。例えば、親水性鎖(b)と親水性リンカー(c)がいずれも、ポリエチレングリコールを含むものであることが好ましい。 In addition, it is preferable that the hydrophilic chain (b) and the hydrophilic linker (c) are both composed of the same hydrophilic polymer. For example, it is preferable that the hydrophilic chain (b) and the hydrophilic linker (c) both contain polyethylene glycol.

 光分解性リンカー(d)は、可視光や紫外線等の光照射によって分解し得る官能基を含む。これにより、疎水性鎖(a)において標的細胞を捕捉した後に、光照射を行うことで、標的細胞を基材表面から分離して回収することができる。また、後述のように、光分解性細胞固定化剤により基材表面全体を修飾した後に、特定の領域に光照射を行うことで疎水性鎖(a)を予め脱離させて、所望の領域のみが細胞結合性を有するようにパターニングすることも可能となる。 The photocleavable linker (d) contains a functional group that can be decomposed by irradiation with light such as visible light and ultraviolet light. Thus, target cells can be separated and collected from the surface of the substrate by performing light irradiation after capturing the target cells in the hydrophobic chain (a). Also, as described later, after the entire surface of the base material is modified with a photolytic cell fixing agent, the hydrophobic chain (a) is detached in advance by irradiating a specific area with light, and a desired area is obtained. It is also possible to pattern so as to have cell binding property.

 光分解性リンカー(d)における光照射によって分解し得る官能基としては、光反応によって親水性リンカー(c)と親水性鎖(b)を切断できるものであれば特に限定されないが、例えば、2-ニトロベンジル骨格、クマリン-4-イルメチル骨格、フェニルカルボニルメチル骨格又は7-ニトロインドリノカルボニル骨格を有する二価の基を用いることができる。好ましくは、2-ニトロベンジル骨格を有する二価のである。 The functional group of the photodegradable linker (d) that can be decomposed by light irradiation is not particularly limited as long as it can cleave the hydrophilic linker (c) and the hydrophilic chain (b) by photoreaction, -A bivalent group having a -nitrobenzyl skeleton, a coumarin-4-ylmethyl skeleton, a phenylcarbonylmethyl skeleton or a 7-nitroindolinocarbonyl skeleton can be used. Preferably, it is bivalent having a 2-nitrobenzyl skeleton.

 本発明の光分解性細胞固定化剤の具体例としては、以下の構造を有する化合物を挙げることができる。

Figure JPOXMLDOC01-appb-C000008
As a specific example of the photodegradable cell fixing agent of the present invention, a compound having the following structure can be mentioned.
Figure JPOXMLDOC01-appb-C000008

 当該化合物は、疎水性鎖(a)としてオレイル基;親水性鎖(b)及び親水性リンカー(c)としてポリエチレングリコール鎖;光分解性リンカー(d)に2-ニトロベンジル基を有し;及び、基材との結合のために親水性鎖(b)の末端にN-ヒドロキシスクシンイミドを有している。式中、mは、2より大きい自然数であり、nは、50以上の自然数である。上述のように、mは、好ましくは、好ましくは、3~100の自然数であり、より好ましくは、mは、4~8の自然数である。 The compound has an oleyl group as the hydrophobic chain (a); a polyethylene glycol chain as the hydrophilic chain (b) and the hydrophilic linker (c); a 2-nitrobenzyl group in the photocleavable linker (d); And N-hydroxysuccinimide at the end of the hydrophilic chain (b) for binding to a substrate. In the formula, m is a natural number greater than 2, and n is a natural number of 50 or more. As mentioned above, m is preferably preferably a natural number of 3 to 100, more preferably m is a natural number of 4 to 8.

2.細胞固定化用基材及び製造方法
 本発明は、また、上記光分解性細胞固定化剤によって修飾された表面を有する細胞固定化用基材にも関する。当該細胞固定化用基材の表面構造は、上述のとおり、光分解性細胞固定化剤が親水性鎖(b)の末端で基材表面に直接或いは後述の被覆層を介して結合したものである。光分解性細胞固定化剤は、好ましくは、基材の表面に単分子膜状に配列される。
2. The present invention also relates to a cell immobilizing substrate having a surface modified with the above-mentioned photolyzable cell immobilizing agent. The surface structure of the cell immobilizing substrate is, as described above, a photocleavable cell fixing agent bound to the surface of the substrate directly at the end of the hydrophilic chain (b) or via a covering layer described later. is there. The photocleavable cell fixing agent is preferably arranged in the form of a monolayer on the surface of the substrate.

 光分解性細胞固定化剤によって修飾される基材の材質や形状等は特に限定されず、その用途等に応じて適当な基材を種々選択することができる。例えば、修飾対象の基材の形状は、基板状(プレート状又はフィルム状のもの、例えばスライドガラス、ディッシュ、マイクロプレート、マイクロアレイ用基板等)であっても、担体(例えばビーズなどの粒子状やコロイド状のもの)、繊維状構造物、管、容器(例えば試験管及びバイアル)であってもよい。修飾対象基材の材質としては、ガラス;セメント;陶磁器等のセラミックスもしくはファインセラミックス;ポリエチレンテレフタレート、酢酸セルロース、ポリカーボネート、ポリスチレン及びポリメチルメタクリレートなどのポリマー樹脂;ポリペプチド及びタンパク質などの生体材料;シリコン;活性炭;多孔質ガラス;多孔質セラミックス;多孔質シリコン;多孔質活性炭;不織布;濾紙;メンブレンフィルター;金などの導電性材料、などが挙げられる。修飾対象基材の表面は、アミノ基、カルボキシル基、ヒドロキシ基などを導入するため、ポリ陽イオンなどのポリマーによる被覆処理、あるいは基材表面への導入置換基を有するシランカップリング剤による処理が施されていてもよいし、あるいはプラズマ処理により反応性官能基が導入されていてもよい。 The material, shape, and the like of the base material to be modified by the photodegradable cell fixing agent are not particularly limited, and various suitable base materials can be selected according to the use and the like. For example, even if the shape of the substrate to be modified is a substrate (plate or film, for example, a slide glass, a dish, a microplate, a substrate for microarray, etc.), the carrier (for example, particles such as beads) or It may be colloidal), fibrous structures, tubes, containers (eg test tubes and vials). Materials of the substrate to be modified include glass; cement; ceramics or fine ceramics such as chinaware; polymer resins such as polyethylene terephthalate, cellulose acetate, polycarbonate, polystyrene and polymethyl methacrylate; biomaterials such as polypeptide and protein; silicon; Activated carbon; porous glass; porous ceramics; porous silicon; porous activated carbon; nonwoven fabric; filter paper; membrane filter; conductive material such as gold, etc. may be mentioned. In order to introduce amino groups, carboxyl groups, hydroxy groups, etc., the surface of the substrate to be modified is coated with a polymer such as polycation or treated with a silane coupling agent having a substituent introduced onto the substrate surface. It may be applied, or reactive functional groups may be introduced by plasma treatment.

 光分解性細胞固定化剤は、基材表面と直接結合することで修飾されてもよいし、或いは、基材表面に被覆層を設け、当該被覆層の表面に光分解性細胞固定化剤を結合させて表面修飾を行うこともできる。かかる被覆層としては、例えば、コラーゲンやウシ血清アルブミン(BSA)、3-アミノプロピルトリエトキシシラン(APTES)、卵白アルブミンを用いることができる。 The photolytic cell fixing agent may be modified by direct bonding to the substrate surface, or a coating layer is provided on the substrate surface, and the photolytic cell fixing agent is applied to the surface of the coating layer. It is also possible to carry out surface modification by bonding. As such a coating layer, for example, collagen, bovine serum albumin (BSA), 3-aminopropyltriethoxysilane (APTES), or ovalbumin can be used.

 また、本発明の細胞固定化用基材は、特定の表面領域のみに光分解性細胞固定化剤を有する、パターン化された表面修飾を有することができる。これにより、標的細胞を基材表面の特定の領域に固定化することができる。例えば、1細胞を固定化するためにスポット型の修飾領域を複数有するものとすることができる。一細胞を固定化するためにスポットの直径は、標的細胞の大きさにも依存するが、おおよそ2~30μm、或いは5~15μmであることができる。 In addition, the substrate for cell immobilization of the present invention can have a patterned surface modification having a photolytic cell fixing agent only on a specific surface area. Thereby, target cells can be immobilized on a specific area of the substrate surface. For example, in order to immobilize one cell, a plurality of spot-type modified regions can be provided. The diameter of the spot for immobilizing one cell depends on the size of the target cell, but can be approximately 2 to 30 μm, or 5 to 15 μm.

 かかるパターン化された表面修飾を有する細胞固定化用基材は、図3に示すように、以下の工程により調製することができる。
(A)光分解性細胞固定化剤で基材表面全体を修飾する工程、及び
(B)光分解性細胞固定化剤による表面修飾が特定の領域のみ維持されるように表面をパターン化する工程であって、基材表面における前記特定の領域以外の領域に光を照射して、光分解性細胞固定化剤における光分解性リンカー部分を切断する、該工程。
The substrate for cell immobilization having such a patterned surface modification can be prepared by the following steps as shown in FIG.
(A) modifying the entire substrate surface with a photolytic cell fixing agent, and (B) patterning the surface such that the surface modification with the photolytic cell fixing agent is maintained only in a specific region And irradiating the region other than the specific region on the substrate surface with light to cleave the photocleavable linker moiety in the photocleavable cell fixing agent.

3.細胞の固定化及び回収方法
 さらに、本発明は、光分解性細胞固定化剤により表面修飾した細胞固定化用基材を用いて、標的細胞を固定化し、選択的に回収する細胞選別技術にも関する。本発明の細胞の回収方法は、以下の工程を含む、
(1)細胞固定化用基材に所定の標的細胞を含む溶液を接触させ、前記細胞固定化用基材に前記標的細胞を固定化する工程、
(2)前記細胞固定化用基材に光を照射し、前記細胞固定化用基材の表面の光分解性細胞固定化剤における光分解性リンカー部分を切断することで、前記固定化された標的細胞を前記細胞固定化用基材から分離・回収する工程。
3. Method for Immobilizing and Recovering Cells Furthermore, the present invention is also directed to a cell sorting technique in which target cells are immobilized and selectively recovered using a substrate for cell immobilization which has been surface-modified with a photolytic cell immobilization agent. Related. The cell recovery method of the present invention comprises the following steps:
(1) contacting a solution containing predetermined target cells with a substrate for cell immobilization, and immobilizing the target cells on the substrate for cell immobilization,
(2) The cell immobilization substrate is irradiated with light, and the photocleavable linker moiety in the photodegradable cell immobilization agent on the surface of the cell immobilization substrate is cut, whereby the immobilization is performed. Separating and recovering target cells from the cell immobilization substrate.

 当該方法を行う場として、細胞固定化用基材をマイクロ流路内に設置することができる。工程(2)では、基材表面に流束を付与し、光分解性リンカー部分が切断された後の標的細胞を回収することができる。 A base for cell immobilization can be placed in the microchannel as a place to perform the method. In step (2), a flux can be applied to the surface of the substrate to recover target cells after cleavage of the photocleavable linker moiety.

 上述のように、基材表面をパターン化し、1細胞を固定化するためにスポット型の修飾領域を複数有するものとすることにより、一細胞を固定化・回収することが可能となる。 As described above, it is possible to immobilize and recover one cell by patterning the substrate surface and having a plurality of spot-type modified regions for immobilizing one cell.

 以下、実施例により本発明をさらに詳細に説明するが、本発明はこれらによって限定されるものではない。 Hereinafter, the present invention will be described in more detail by way of examples, but the present invention is not limited thereto.

1.光分解性細胞固定化剤の合成
 以下のスキームにより、本発明の光分解性細胞固定化剤であるPEG脂質(PEG)P-BAMの合成を行った。(PEG)P-BAMは、親水性リンカー部がm=4である。親水性リンカー部の長さが異なるm=2、8、40についても同様の手法により合成を行った。
1. Synthesis of Photodegradable Cell Fixing Agent Synthesis of PEG lipid (PEG 4 ) P-BAM, which is a photodegradable cell fixing agent of the present invention, was performed according to the following scheme. (PEG 4 ) P-BAM has a hydrophilic linker of m = 4. The synthesis was performed in the same manner for m = 2, 8 and 40 different in the length of the hydrophilic linker moiety.

Figure JPOXMLDOC01-appb-C000009
Figure JPOXMLDOC01-appb-C000009

1-1. 化合物2の合成

Figure JPOXMLDOC01-appb-C000010
100mlナス型フラスコに化合物1 (2.9950 g, 18.0 mmol)、K2CO3 (4.0808 g)、DMF (20 ml)、4-ブロモ酪酸メチル (2.6 ml, 20.6 mmol, 1.14 eq)を順に加え撹拌。o/nで撹拌後TLC (CHCl3:CH3OH=10:1, Rf: compound 1 = 0.70, target=0.75)で原料(化合物1)の消失を確認。純水をK2CO3やKBrが溶けるまで加え、TLCで確認しながら酢酸エチルとBrineで分液を三回行い、水層から生成物を回収した。有機層を三角フラスコに回収して硫酸マグネシウムで乾燥後、吸引ろ過で硫酸マグネシウムを除去し、溶媒を減圧除去して薄い褐色のオイルを得た。未反応の4-ブロモ酪酸エチルを除くため、シリカカラム精製 (酢酸エチル:ヘキサン=4:6)を行った。目的の生成物を21-44本目に回収し(49本中)、減圧留去後、o/nで真空乾燥し化合物2を得た。同定は1H-NMR (CDCl3)で行った(Fig. 5-7)。収量は4.2434 g、収率は88 %であった 1-1. Synthesis of compound 2
Figure JPOXMLDOC01-appb-C000010
100ml eggplant type flask Compound 1 (2.9950 g, 18.0 mmol) , K 2 CO 3 (4.0808 g), DMF (20 ml), 4- bromo-butyric acid methyl (2.6 ml, 20.6 mmol, 1.14 eq) and stirring was added sequentially. After stirring at o / n, disappearance of the raw material (compound 1) was confirmed by TLC (CHCl 3 : CH 3 OH = 10: 1, Rf: compound 1 = 0.70, target = 0.75). Pure water was added until K 2 CO 3 and KBr were dissolved, and the solution was separated three times with ethyl acetate and Brine while confirming by TLC, and the product was recovered from the aqueous layer. The organic layer was collected in an Erlenmeyer flask and dried over magnesium sulfate, and then the magnesium sulfate was removed by suction filtration, and the solvent was removed under reduced pressure to obtain a pale brown oil. In order to remove unreacted ethyl 4-bromobutyrate, silica column purification (ethyl acetate: hexane = 4: 6) was performed. The desired product was collected at the 21st to 44th columns (of 49), evaporated under reduced pressure, and dried in vacuo at o / n to give compound 2. Identification was performed by 1 H-NMR (CDCl 3 ) (Fig. 5-7). The yield was 4.2434 g, 88%

1-2. 化合物3の合成

Figure JPOXMLDOC01-appb-C000011
実験は全てドラフト内で行った。on iceで200 mlナスフラスコに69 %硝酸(60 ml)をいれ、そこに撹拌しながら無水酢酸(12 ml)をパスツールピペットで少しずつ滴下した。さらに無水酢酸(12 ml)に溶かした化合物2 (3.0021 g, 11.2 mmol)をパスツールピペットで少しずつ滴下したところ、溶液が黄色透明になった。2 h 30 min撹拌した後、on ice (with NaCl)で冷やしておいた三角フラスコ中の純水(300 ml)にパスツールピペットで反応液を少しずつ滴下し、薄黄色沈殿を得た。(間違って-30 °C で一晩静置した後)、4℃で5 h静置し、沈殿を吸引濾過で回収して純粋で洗浄後、デシケーターで一晩真空乾燥させ、薄黄色の化合物3を得た、収量は1.8726 g。収率は53.4 %であった。同定は1H-NMR(CDCl3)でおこなった(Fig. 5-8)。 1-2. Synthesis of compound 3
Figure JPOXMLDOC01-appb-C000011
All experiments were conducted in the draft. 69% nitric acid (60 ml) was put into a 200 ml eggplant flask on ice, and acetic anhydride (12 ml) was dropped little by little with a Pasteur pipette while stirring there. Furthermore, when the compound 2 (3.0021 g, 11.2 mmol) dissolved in acetic anhydride (12 ml) was dripped little by little with a Pasteur pipette, the solution became yellowish transparent. After stirring for 2 h 30 min, the reaction solution was added little by little with a Pasteur pipette to pure water (300 ml) in an Erlenmeyer flask cooled with on ice (with NaCl) to obtain a pale yellow precipitate. (Incorrectly after standing at -30 ° C overnight), stand at 4 ° C for 5 h, collect precipitate by suction filtration, wash with pure, vacuum dry with a desiccator overnight, light yellow compound Obtained 3, the yield is 1.8726 g. The yield was 53.4%. Identification was performed by 1 H-NMR (CDCl 3 ) (FIG. 5-8).

1-3. 化合物4の合成

Figure JPOXMLDOC01-appb-C000012
実験は全てドラフト内で行った。100 ml枝付きナスフラスコ内に化合物3 (1.4953 g, 4.8 nmol)を入れ、dry up、N2置換後にdry THF (25 ml)とdry MeOH (14 ml)を加えon iceで撹拌したところ黄色に懸濁した溶液になった。NaBH4 (0.3323 g, 8.8 mmol, 1.83eq)を粉末として加え、気体が発生している間はon iceで撹拌し、気体が収まった後はr.t.でo/nで反応させた(頂いた資料では15 h反応)。TLC (CHCl3:CH3OH=20:1, Rf:原料=0.55, 反応中間体=0.38)で原料消失を確認後、4 M NaOH (3 ml)と純水(10 ml)を加えて次の加水分解の反応に移った。3 h 30 min反応後、TLC (Rf:target=0.14)で反応中間体消失mを確認し、溶媒を減圧除去。黄褐色透明溶液になったが、その後を引き続けたところ褐色固体になった。ここに10 M HCl (2 ml)と純水を加えたところ溶液がコロイド化してしまった。約200 mlの酢エチを加えて溶解させた後、酢エチで抽出。TLCで水層に生成物が無いことを確認後、MgSO4を加えて乾燥し、吸引濾過でMgSO4を除去した後、溶媒を減圧除去した。真空乾燥を経てオレンジ色の固体を得た。その後、生成物を酢エチに溶かして減圧除去で飽和させ、ヘキサンを滴下時の靄が消えなくなるまで滴下し、-20℃で静置、析出した沈殿を吸引濾過で回収することを3回繰り返し、再結晶をおこなった。この際1,2回目は黄白色のペースト状の固体、3回目はオレンジ色の粉末が得られた。得られた固体を真空乾燥し、化合物4を得た。同定は1H-NMR (DMSO-d6)で行い(Fig. 5-9)、収量は1.0992 g (1,2回目0.95 g、3回目0.1492 g)、収率は76.4 %であった。 1-3. Synthesis of compound 4
Figure JPOXMLDOC01-appb-C000012
All experiments were conducted in the draft. Compound 3 (1.4953 g, 4.8 nmol) was placed in a 100 ml branched eggplant flask, and after dry up, N 2 substitution, dry THF (25 ml) and dry MeOH (14 ml) were added and stirred with ice. It became a suspended solution. NaBH 4 (0.3323 g, 8.8 mmol, 1.83 eq) was added as a powder, and while gas was being generated, stirring was performed on ice, and after the gas was settled, reaction was performed at o / n at rt (data provided) In the 15 h reaction). After confirming the disappearance of the raw materials by TLC (CHCl 3 : CH 3 OH = 20: 1, Rf: raw material = 0.55, reaction intermediate = 0.38), 4 M NaOH (3 ml) and pure water (10 ml) are added, and the next Transferred to the reaction of hydrolysis of After 3 h 30 min reaction, disappearance of reaction intermediate m is confirmed by TLC (Rf: target = 0.14), and the solvent is removed under reduced pressure. It became a yellow-brown clear solution, but it continued to become a brown solid as it continued to pull. When 10 M HCl (2 ml) and pure water were added to the solution, the solution became colloidal. Add about 200 ml of vinegar and dissolve it, then extract with vinegar. After confirming that there was no product in the aqueous layer by TLC, the reaction solution was added with MgSO 4 for drying, and after suction filtration to remove MgSO 4 , the solvent was removed under reduced pressure. After vacuum drying, an orange solid was obtained. Thereafter, the product is dissolved in vinegar and saturated by removal under reduced pressure, hexane is added dropwise until the drop in the dropping does not disappear, and the mixture is allowed to stand at -20 ° C, and the precipitated precipitate is collected by suction filtration three times repeatedly. , Recrystallized. At this time, a yellowish white paste-like solid was obtained in the first and second times, and an orange powder was obtained in the third time. The resulting solid was dried under vacuum to give compound 4. The identification was performed by 1 H-NMR (DMSO-d6) (FIG. 5-9), and the yield was 1.0992 g (1,2nd 0.95 g, 3rd 0.1492 g), and the yield was 76.4%.

1-4. 化合物10の合成

Figure JPOXMLDOC01-appb-C000013
50 mlふた口フラスコにEDC 442.6 mg (2.30 mmol)とHOBt 154.9 mg (1.14 mmol)を加えて真空引き、窒素置換後20 mlのdry DCMを加えて撹拌し完全に溶解させた。ここに387.6 mg (1.06 mmol)の化合物9をテルモシリンジで加えた後、450 μl (1.36 mmol)のOleylamineをテルモシリンジで加えた。学会を挟んで約6日撹拌後TLC (DCM/MeOH=7/1, Rf: 化合物9=0.5, oleylamine=0.16, product=0.58)で原料の消失を確認し、シリカカラム(DCM/MeOH=9/1)にかけ、目的物画分を濃縮し淡黄色のオイルを得た。収量は572.6 mg、収率は84.5 %だった。1H-NMR (DMSO-d6)とESI-MSにより目的物の生成を確認した(Fig. 5-10)。HOBtが0.17当量混入したものが得られた。 1-4. Synthesis of compound 10
Figure JPOXMLDOC01-appb-C000013
442.6 mg (2.30 mmol) of EDC and 154.9 mg (1.14 mmol) of HOBt were added to a 50 ml two-necked flask, vacuum was applied, 20 ml of dry DCM was added after nitrogen substitution, and the mixture was stirred to dissolve completely. After 387.6 mg (1.06 mmol) of Compound 9 was added thereto via a thermo syringe, 450 μl (1.36 mmol) of Oleylamine was added via a thermo syringe. After stirring for about 6 days across the academic society, disappearance of the raw materials was confirmed by TLC (DCM / MeOH = 7/1, Rf: compound 9 = 0.5, oleylamine = 0.16, product = 0.58), and a silica column (DCM / MeOH = 9) The desired product fraction was concentrated to give a pale yellow oil. The yield was 572.6 mg, and the yield was 84.5%. The formation of the desired product was confirmed by 1 H-NMR (DMSO-d6) and ESI-MS (FIG. 5-10). What HOBt mixed with 0.17 equivalent was obtained.

1-5. 化合物12の合成

Figure JPOXMLDOC01-appb-C000014
1-5. Synthesis of Compound 12
Figure JPOXMLDOC01-appb-C000014

1工程目
(m=4の場合)
20 mlの二口ナスフラスコに化合物10を100.7 mg (163 μmol)をいれ、3 ml酢酸エチルを入れて撹拌し、そこに1.5 ml 12 M HClを滴下した。o/nで反応後、TLC (DCM/MeOH=7/1, Rf: 10=0.67, 11=0.23, ヨウ素呈色)で反応の終了を確認、エバポレーターで溶媒を除去し、真空乾燥後した。
1st process
(in the case of m = 4)
100.7 mg (163 μmol) of the compound 10 was put in a 20 ml two-necked eggplant flask, 3 ml ethyl acetate was added and stirred, and 1.5 ml 12 M HCl was dropped thereto. After completion of the reaction at o / n, TLC (DCM / MeOH = 7/1, Rf: 10 = 0.67, 11 = 0.23, iodine color) confirmed completion of the reaction, the solvent was removed by an evaporator, and the residue was dried under vacuum.

(m=8の場合) *m=2の場合も同様
50 mlのナスフラスコに化合物10 を39.6 mg (43.8 μmol)加え、5 mlのMeOHに溶解した。そこに0.5 mlの2 M NaOH aqを加え、室温で1時間撹拌した。TLC (DCM/MeOH = 10/1, Rf: 10=0.49, 11=0.1)で反応の終了を確認した。MeOHを留去した後、酢酸エチルで3回抽出を行い、硫酸ナトリウムで乾燥後、エバポレーターで濃縮・真空乾燥を行った。
(in the case of m = 8) * also in the case of m = 2
39.6 mg (43.8 μmol) of compound 10 was added to a 50 ml eggplant flask and dissolved in 5 ml of MeOH. 0.5 ml of 2 M NaOH aq was added there, and it stirred at room temperature for 1 hour. The termination of the reaction was confirmed by TLC (DCM / MeOH = 10/1, Rf: 10 = 0.49, 11 = 0.1). After MeOH was distilled off, extraction was performed three times with ethyl acetate, dried over sodium sulfate, and concentrated and vacuum dried with an evaporator.

2工程目
(m=4の場合) *m=2,8の場合も同様
クルードの化合物11が含まれる二口ナスフラスコに対し、65.4 mg (218 μmol)の化合物4、63.6 mg (331 μmol)のEDCと200 μl dry TEAを加えて真空引き、窒素置換後dry DCMを加えて撹拌したところ黄色透明の溶液になった。o/nで反応後、TLCで反応の終了を確認し、シリカカラム(DCM/MeOH=7/1)にかけ、目的物画分をESIで確認後、濃縮・真空乾燥して茶色のオイルを得た。収量は138 mg、収率は副生成物を加味して76.4 %である。
2nd process
(in the case of m = 4) * 65.4 mg (218 μmol) of the compound 4 and 63.6 mg (331 μmol) of EDC with a two-necked eggplant flask containing the crude compound 11 also in the case of m = 2, 8 After adding 200 μl dry TEA and evacuating and replacing with nitrogen, the solution was stirred with dry DCM to obtain a yellow clear solution. After completion of the reaction at o / n, TLC confirmed completion of the reaction, applied to silica column (DCM / MeOH = 7/1), target fraction was confirmed by ESI, concentrated and dried under vacuum to obtain brown oil The The yield is 138 mg and the yield is 76.4% taking into account by-products.

1-6. 化合物13の合成

Figure JPOXMLDOC01-appb-C000015
50 ml二口ナスフラスコに化合物12を46.6 mg (60.8 μmol)とクロロギ酸ニトロフェニルを10.9 mg (54.2 μmol)加えて一晩真空乾燥後、窒素置換し10 mlのdry DCMと、200 μlのdry TEAを加えて反応を開始させた。約二日撹拌してもTLC (DCM/MeOH=8/1, Rf: s.m.=0.53, target=0.60)で反応が進行している様子が確認できず、ESI、1H-NMR (DMSO-d6)でも反応の進行が確認できなかったため、溶媒を除去し、70 mg (348 μmol)のクロロギ酸ニトロフェニルを加えて真空乾燥、窒素置換後、dry DCMを10 mlとdry TEAを100 μl加えて反応を開始させた。2時間後、TLCで反応の終了を確認し、溶媒を除去、真空乾燥後、シリカカラム(DCM/MeOH=10/1)にかけたところ、目的物とクロロギ酸ニトロフェニルが分離できなかったため、シリカカラム(DCM/MeOH=20/1)にかけなおし、目的物画分をESIで確認、濃縮した。収量は85.2 mg、収率は85 %であった。クロロギ酸ニトロフェニルの加水分解体が3.29等量含まれているものが得られた。同定は1H-NMR (DMSO-d6)およびESI-MSにより行った(Fig. 5-12)。 1-6. Synthesis of compound 13
Figure JPOXMLDOC01-appb-C000015
After adding 46.6 mg (60.8 μmol) of compound 12 and 10.9 mg (54.2 μmol) of nitrophenyl chloroformate to a 50 ml two-necked eggplant flask and drying under vacuum overnight, the flask is purged with nitrogen and 10 ml of dry DCM and 200 μl of dry The reaction was initiated by the addition of TEA. Even after stirring for about two days, it was not possible to confirm that the reaction was proceeding by TLC (DCM / MeOH = 8/1, Rf: sm = 0.53, target = 0.60), and ESI, 1 H-NMR (DMSO-d6 But the reaction progress could not be confirmed, so remove the solvent, add 70 mg (348 μmol) of nitrophenyl chloroformate, vacuum dry, replace with nitrogen, add 10 ml of dry DCM and 100 μl of dry TEA. The reaction was started. After 2 hours, TLC confirmed the completion of the reaction, the solvent was removed, the residue was dried under vacuum and then applied to a silica column (DCM / MeOH = 10/1), the target substance and nitrophenyl chloroformate could not be separated, so silica The column (DCM / MeOH = 20/1) was applied again, and the objective fraction was confirmed by ESI and concentrated. The yield was 85.2 mg, and the yield was 85%. One containing 3.29 equivalents of the hydrolyzate of nitrophenyl chloroformate was obtained. Identification was performed by 1 H-NMR (DMSO-d6) and ESI-MS (FIG. 5-12).

1-7. 化合物14の合成

Figure JPOXMLDOC01-appb-C000016
50 ml二口ナスフラスコに保存していた65.3 mg (40.13 μmol)の化合物13に対し、101.4 mg (29.8 μmol)のPA-034HCを加え、dry up、窒素置換後、10 mlのdry DCMと200 μlのdry TEAを加えて反応を開始させた。約二日撹拌後、TLC(DCM/MeOH=6/1, Rf: 13=0.48, PA-034HC=0.33, target=0.44?) で反応の終了を確認し、エーテル沈殿で目的物を回収、混入していたジクロロメタンに不要な固形物を濾過で除いて目的物を得た。この時点での収量は125.1 mg、収率は99 %であった。1H-NMR (DMSO)を取ったところクロロギ酸ニトロフェニルの加水分解体が混入していたため、試しにエタノール沈殿にかけてみた後に1H-NMR (DMSO)を取ったところ、純度良く目的物が得られた。最終的な収量は89 mg、収率は70.6 %であった。PA-034HCの未反応物のピークはNMRで観察されなかった。同定は1H-NMR (DMSO-d6)により行った(Fig. 5-13)。 1-7. Synthesis of Compound 14
Figure JPOXMLDOC01-appb-C000016
To 65.3 mg (40.13 μmol) of compound 13 stored in a 50 ml two-necked eggplant flask, 101.4 mg (29.8 μmol) of PA-034HC was added, and dry up, after nitrogen substitution, 10 ml of dry DCM and 200 The reaction was initiated by adding μl of dry TEA. After stirring for about two days, the end of the reaction is confirmed by TLC (DCM / MeOH = 6/1, Rf: 13 = 0.48, PA-034HC = 0.33, target = 0.44?), And the target substance is recovered by ether precipitation and contaminated The unnecessary solid was removed by filtration to obtain the desired product. The yield at this point was 125.1 mg, and the yield was 99%. When 1 H-NMR (DMSO) was taken, the hydrolyzate of nitrophenyl chloroformate was mixed. Therefore, after trying ethanol precipitation as a trial, 1 H-NMR (DMSO) was taken, and the desired product was obtained with high purity. It was done. The final yield was 89 mg, and the yield was 70.6%. The peak of unreacted PA-034 HC was not observed by NMR. Identification was performed by 1 H-NMR (DMSO-d6) (Fig. 5-13).

1-8. 化合物15((PEG)P-BAM)の合成

Figure JPOXMLDOC01-appb-C000017
50 mlの二口ナスフラスコに55.5 mg (13.1 μmol)の化合物14と146.6 mg (711 μmol)のDCC、16.4 mg (142 μmol) のNHSを加え、真空乾燥、窒素置換後、10 mlのdry DCMと100 μlのdry TEAを加えて反応を開始させた。約二日撹拌後、反応液を濾過、濃縮後、エーテル沈殿で目的物を回収し、1H-NMR (DMSO)で同定を行った(Fig. 5-14)。DCCのウレアが0.38 eq含まれたものが得られ、収量は53.5 mg、収率は92 %だった。実際の分子量は4404として今後も扱った。(目的物のMw=4319) 1-8. Synthesis of Compound 15 ((PEG 4 ) P-BAM)
Figure JPOXMLDOC01-appb-C000017
Add 55.5 mg (13.1 μmol) of compound 14 and 146.6 mg (711 μmol) of DCC, 16.4 mg (142 μmol) of NHS to a 50 ml two-necked eggplant flask, vacuum dry, replace with nitrogen, and then 10 ml of dry DCM The reaction was started by adding 100 μl of dry TEA. After stirring for about two days, the reaction solution was filtered and concentrated, and then the target substance was collected by ether precipitation, and identification was performed by 1 H-NMR (DMSO) (FIG. 5-14). One containing 0.38 eq of urea of DCC was obtained, the yield was 53.5 mg, and the yield was 92%. The actual molecular weight was further treated as 4404. (Object Mw = 4319)

2. 基板調整
 以下の手順で光分解性細胞固定化剤によるガラス基板の表面修飾を行った。
2. Substrate preparation Surface modification of the glass substrate with the photodegradable cell fixing agent was performed in the following procedure.

2-1. 基盤の初期洗浄
 スライドガラスをドーゼに入れ、アルカリスキャットを含む水中で10分間超音波洗浄機にかけた。アルカリスキャットを含む水をアセトンに換えて同じ操作を行い、その後イソプロパノール→アセトン→イソプロパノールの順で同じ洗浄を行ったのち、風乾した。
2-1. Initial Cleaning of Substrate The slide glass was placed in a dose and subjected to an ultrasonic cleaner for 10 minutes in water containing alkaline scat. The same operation was carried out by replacing water containing alkaline scat with acetone, and after performing the same washing in the order of isopropanol → acetone → isopropanol, air-dried.

2-2. 基盤のコラーゲンコーティング
 4-well dishの各wellの両端にスペーサーを置き、スライドガラスがウェルの底面に触れないようにした。コラーゲン(3 mg/ml, pH 3)をHClでpH 3に合わせたMQで10倍希釈して0.3 mg/mlとし、4-well dishの各wellに4 mlずつ注いだ。初期洗浄を済ませたスライドガラスを各wellに1枚ずつ浸し、遮光して室温で一晩静置した。翌日ドーゼを使用してMQで三回すすいだ後、風乾した。使用済みのスペーサーはエタノール中に保管し、再利用する。35 mmガラスボトムディッシュをコーティングする際は、溶液量は200 μlで行い、洗浄はアスピレーターまたはピペットマンを使用して行った。
2-2. Collagen coating on the base A spacer was placed at each end of each well of the 4-well dish so that the slide glass did not touch the bottom of the well. Collagen (3 mg / ml, pH 3) was diluted 10-fold with MQ adjusted to pH 3 with HCl to make 0.3 mg / ml, and 4 ml was poured into each well of 4-well dishes. The slide glass which had been subjected to the initial washing was immersed one by one in each well, shielded from light and allowed to stand overnight at room temperature. The next day, after rinsing three times with MQ using a dose, air-dried. Store used spacers in ethanol for reuse. When coating a 35 mm glass bottom dish, the solution volume was 200 μl and washing was performed using an aspirator or pipetman.

2-3. 基板の光分解性細胞固定化剤(PEG脂質)修飾(スポット法)
 修飾に用いるPEG脂質はdry DMSOで10 mMになるように溶解して調製し、5 μlずつ分注してAr置換後、-20 °Cで保存した。このストック溶液を使用直前に495 μlのPBS-で希釈して100 μMとし、流路中心に1 cm間隔で0.3 μlずつ計三点スポットする4-well dishにいれて、インキュベーター(37 °C, CO2 5 %)内で1時間インキュベートし、その後、MQで6回washし、風乾した。
2-3. Photolytic cell immobilization agent (PEG lipid) modification of substrate (spot method)
The PEG lipid to be used for modification was prepared by dissolving it in dry DMSO so as to be 10 mM, aliquoted in 5 μl aliquots, and stored at −20 ° C. after Ar substitution. This stock solution is diluted with 495 μl of PBS- to 100 μM immediately before use, and placed in a 4-well dish where 0.3 μl of total 0.3 μl spots are placed at 1 cm intervals in the center of the channel, and the incubator (37 ° C, Incubate for 1 hour in 5% CO 2 ), then wash 6 times with MQ and air dry.

3.細胞調整
3-1.細胞の解凍・培養・凍結
解凍
 血清入り培地を37 °C恒温槽で温めておき、冷凍していた細胞を恒温槽で氷が少し残るくらいまで溶かした。溶けきったらすぐに全量を15 mlチューブに移し、9 mlの培地で希釈した。遠心(190 G, 3 min, 以下同)して上清を除き、10 mlの培地に再懸濁して100 mmディッシュにまいた。
培養
 基本的にインキュベーター中で培養(37 °C, 5 % CO2)。培地組成は以下の通り。
eGFP発現Ba/F3: RPMI (10 % FBS), 1 ng/ml IL3
継代
 Ba/F3は、基本新しい培地で希釈するだけである。
凍結
 細胞を15 mlチューブに回収し、一度きれいな培地で洗った後、Cell Bankerに懸濁させて0.5 or 1 mlずつ分注し、-80 °Cで保管する。長期保管サンプルは液体窒素中で保管した。
3. Cell Regulation 3-1. Thaw / culture / freeze cells
The thawed serum-containing medium was warmed in a thermostat at 37 ° C., and the frozen cells were thawed in the thermostat until some ice remained. Immediately after complete dissolution, the whole was transferred to a 15 ml tube and diluted with 9 ml of medium. The supernatant was removed by centrifugation (190 G, 3 min, same or less), resuspended in 10 ml of medium and plated in a 100 mm dish.
Cultivation Incubate basically in an incubator (37 ° C, 5% CO 2 ). The medium composition is as follows.
eGFP expressing Ba / F3: RPMI (10% FBS), 1 ng / ml IL3
Passage Ba / F3 is only diluted in basic fresh medium.
Frozen cells are collected in a 15 ml tube, washed once with a clean medium, suspended in Cell Banker, aliquoted in 0.5 or 1 ml aliquots, and stored at -80 ° C. Long term storage samples were stored in liquid nitrogen.

3-2. 細胞固定に向けた細胞の前処理
 Ba/F3を遠心(100 G, 3 min, 以下同)で回収後、10 ml PBS-で二度洗浄し、3×106 cell/mlになるようにPBS-に再懸濁した。
3-2. Pretreatment of cells for cell fixation After collecting Ba / F3 by centrifugation (100 G, 3 min, same or less), wash twice with 10 ml PBS- to 3 × 10 6 cells / ml Were resuspended in PBS- as indicated.

4.光パターニング
 光照射は朝日分光のMAX-302を使用し、フィルターはLX0360 (360 nm ± 2 nm)を使用した。光照射は光量測定器で測定した光量をもとに、MAX-302のタイマー機能を使用して自動照射した。フォトマスクを介して照射を行う際は、下からの投光に対し、フォトマスクのマスクの面を上に向け、その上にダイレクトに基盤をPEG脂質が修飾されている面を下に向けておくことでコンタクト露光を行った。
4. Photopatterning Photoirradiation was used with Asahi Spectrometer MAX-302, and a filter was used with LX0360 (360 nm ± 2 nm). The light was automatically emitted using the MAX-302 timer function based on the amount of light measured by the light amount meter. When irradiating through a photo mask, the surface of the mask of the photo mask faces up and the base of the substrate is modified with the PEG-modified surface facing down, with respect to light from below. Contact exposure was performed by putting.

5.細胞固定力評価
 次いで、光分解性細胞固定化剤(PEG脂質)で修飾した基板を用いて細胞固定化能を評価した。
5. Evaluation of Cell Fixation Ability Next, the cell fixation ability was evaluated using a substrate modified with a photolytic cell fixation agent (PEG lipid).

5-1. 流路系の作成
 チューブを初めとした流路のパーツを組み合わせ、マイクロ流路を作成した。流路をつなぐときは圧力がかからないよう、また気泡が混入しないよう注意を払って行った。Ibidiのカバー型の流路は初回使用時、4-well dish中で1 %のBSAに10分間浸してコーティングを行い、使用後はアルカリスキャットを加えた水でドーゼを使用して超音波洗浄を行った。
5-1. Creation of channel system The parts of the channel including the tube were combined to create a microchannel. When connecting the flow paths, care was taken not to apply pressure and to prevent air bubbles from being mixed. Ibidi's cover-type flow path is coated by soaking in 1% BSA for 10 minutes in 4-well dishes at the first use, and after use, ultrasonic cleaning is performed using alkali scat-added water and use went.

5-2. PEG脂質の細胞固定力評価
 マイクロ流路内に種々のPEG脂質を修飾し、細胞がお互いに接触しない密度で流路の底面に固定化する。流路内に緩衝液を種々の流速で流し、その前後で残存する細胞の割合をカウントした。PEG脂質として、上記1で合成した本発明に係る光分解性細胞固定化剤を用いた。それぞれ親水性リンカーの長さが、m=2、4、8、40である、(PEG)P-BAM、(PEG)P-BAM、(PEG)P-BAM、(PEG40)P-BAMの4種を用いた。
5-2. Evaluation of cell immobilization power of PEG lipid Various PEG lipids are modified in the microchannel and immobilized on the bottom of the channel at a density at which cells do not contact each other. Buffer was flowed into the channel at various flow rates, and the percentage of cells remaining before and after that was counted. As the PEG lipid, the photolyzable cell immobilization agent according to the present invention synthesized in the above 1 was used. (PEG2) P-BAM, (PEG4) P-BAM, (PEG8) P-BAM, (PEG40) P, wherein the length of the hydrophilic linker is m = 2 , 4 , 8 , 40, respectively Four types of-BAM were used.

 また、比較例として、親水性リンカーを有しない光分解性PEG脂質についても同様の実験を行った。当該比較例のPEG脂質は、以下の構造を有し、疎水性鎖と親水性鎖の間に光分解性リンカーを有しているが、疎水性鎖と光分解性リンカーが直接連結しており親水性リンカーを有していない。

Figure JPOXMLDOC01-appb-C000018
The same experiment was also performed on a photocleavable PEG lipid having no hydrophilic linker as a comparative example. The PEG lipid of the comparative example has the following structure and has a photocleavable linker between the hydrophobic chain and the hydrophilic chain, but the hydrophobic chain and the photocleavable linker are directly linked: It does not have a hydrophilic linker.
Figure JPOXMLDOC01-appb-C000018

 結果を図4に示す。その結果、従来のPEGリンカーの無い光分解性PEG脂質では、せん断応力に耐えられずに80%以上の細胞が脱離したが、m=4~40の親水性リンカーを有する光分解性PEG脂質では、80%以上の細胞が残存した。このように、親水性リンカーを疎水性鎖と光分解性リンカーとの間に組み込むことで、細胞固定化力を大幅に向上できることが示された。 The results are shown in FIG. As a result, in the conventional PEG-free photodegradable PEG lipid, 80% or more of the cells were detached without being able to withstand shear stress, but a photo-degradable PEG lipid having m = 4 to 40 hydrophilic linkers At least 80% of the cells remained. Thus, it was shown that incorporation of a hydrophilic linker between a hydrophobic chain and a photocleavable linker can significantly improve the cell immobilization power.

5-3. 光照射による細胞脱離
 次に、m=8の親水性リンカーを有する光分解性PEG脂質((PEG8)P-BAM)を修飾した表面に細胞を孤立するように固定化し、種々の強度の光(365 nm)を照射した後に流速3 ml/minで細胞固定化表面をリンスしたところ、光照射量に応じて細胞残存率が低下し、3 J/cm程度の光でほぼすべての細胞が取り外された。結果を図5に示す。このように、親水性リンカーを組み込んで細胞固定化力を強化した本発明の光分解性細胞固定化剤を用いることで、一細胞ずつ固定化された細胞を光照射によって選択的に回収できることが示された。
5-3. Cell detachment by light irradiation Next, cells are immobilized so as to isolate cells on the surface modified with a photocleavable PEG lipid ((PEG 8) P-BAM) having a hydrophilic linker of m = 8. The cell-immobilized surface is rinsed at a flow rate of 3 ml / min after being irradiated with light of a high intensity (365 nm), and the cell survival rate decreases according to the amount of light irradiation, and approximately 3 J / cm 2 of light All cells were removed. The results are shown in FIG. Thus, by using the photodegradable cell fixing agent of the present invention, in which the cell immobilization power is enhanced by incorporating a hydrophilic linker, it is possible to selectively recover the cells immobilized one by one by light irradiation. Indicated.

5-4. 細胞アレイの作成と回収
 上記4に従い、3 J/cm以上の紫外光(365nm)のパターンをマイクロ流路の底面に照射して、細胞が固定化されない表面(光照射によって光分解性細胞固定化剤の疎水性鎖部分が切り放された領域)と固定化される表面(非照射領域)とをパターン化した。細胞懸濁液をマイクロ流路内に導入して、非照射領域の光分解性細胞固定化剤の疎水性鎖と細胞との相互作用を介して細胞を固定化し、2~5 ml/min程度になるように流速を調節してリンスすることにより、光照射領域に非特異に吸着した細胞を洗い流す。これにより、マイクロ流路内に細胞アレイが作製された。
5-4. Preparation and collection of cell array According to the above 4, the bottom surface of the microchannel is irradiated with a pattern of ultraviolet light (365 nm) of 3 J / cm 2 or more, and the surface on which cells are not immobilized The region where the hydrophobic chain part of the degradable cell fixing agent was released and the surface (non-irradiated region) to be fixed were patterned. The cell suspension is introduced into the microchannel, and the cells are immobilized through the interaction of the hydrophobic chain of the photolytic cell fixing agent in the non-irradiated area with the cells, and the cells are about 2 to 5 ml / min. The cells non-specifically adsorbed to the light-irradiated area are washed out by rinsing by adjusting the flow rate to become Thereby, a cell array was produced in the microchannel.

 図6に得られた1細胞マイクロアレイのイメージ画像を示す。図6(a)は、被覆層としてコラーゲンコーティングを行った細胞固定化用基材上に形成されたEGFP発現BaF3細胞アレイの蛍光画像である。図6(a)は、被覆層としてBSAコーティングを行った細胞固定化用基材上に形成されたEGFP発現BaF3細胞アレイの明視野像である。 FIG. 6 shows an image of the obtained 1-cell microarray. FIG. 6 (a) is a fluorescence image of an EGFP-expressing BaF3 cell array formed on a cell immobilization substrate coated with collagen as a covering layer. FIG. 6 (a) is a bright field image of an EGFP-expressing BaF3 cell array formed on a cell immobilization substrate coated with BSA as a coating layer.

次いで、得られた細胞アレイについて、1細胞単位での選択的脱離を行った。0.5 ml/min程度になるように流速を調節し、対象細胞にのみ可視光(405nm)を照射して細胞を脱着させた。選択的脱離前後の蛍光画像を図7に示す。図7に示すように、左図の枠内にのみ光照射を行ったところ、当該枠内に存在する細胞のみが選択的に脱離したことを確認した。 Next, selective detachment in one cell unit was performed on the obtained cell array. The flow rate was adjusted to be about 0.5 ml / min, and only the target cells were irradiated with visible light (405 nm) to desorb the cells. Fluorescence images before and after selective desorption are shown in FIG. As shown in FIG. 7, when light was irradiated only in the frame of the left figure, it was confirmed that only the cells present in the frame were selectively detached.

 光照射前後の蛍光画像の解析により算出した、光照射スポット及び非照射スポットにおける細胞脱離率を図8に示す。この結果は、本発明の細胞固定化用基材を用いることで、光照射により選択的に細胞を脱離可能であることを示すものである。 The cell detachment rate in the light-irradiated spot and the non-irradiated spot calculated by analysis of the fluorescence image before and after light irradiation is shown in FIG. This result shows that cells can be selectively detached by light irradiation by using the substrate for cell immobilization of the present invention.

5-5. 細胞アレイ上での樹状細胞への分化 
 上記5-4と同様に細胞固定化用基材(コラーゲンコーティング)上に1細胞アレイを形成し、マウスから採取した単球を6日間培養した。抗CD11抗体PEコンジュゲートで免疫染色した後の画像(蛍光と明視野の重ね合わせ像)を図9に示す。樹状細胞の形成が確認され、細胞アレイ表面上での初期培養・分化が可能であることを確認した。分化効率は45%であった。
5-5. Differentiation to dendritic cells on cell array
A 1-cell array was formed on a substrate for cell immobilization (collagen coating) in the same manner as in 5-4 above, and monocytes collected from mice were cultured for 6 days. An image (superimposed image of fluorescence and bright field) after immunostaining with an anti-CD11 antibody PE conjugate is shown in FIG. The formation of dendritic cells was confirmed, and it was confirmed that initial culture / differentiation on the cell array surface is possible. The differentiation efficiency was 45%.

Claims (16)

 所定の標的細胞を基材上に固定するための光分解性細胞固定化剤であって、
前記標的細胞と相互作用し得る疎水性鎖、
前記基材の表面に単分子膜状に配列し得る親水性鎖、及び
前記疎水性鎖と親水性鎖を連結する親水性リンカー及び光分解性リンカー
を有し、
 前記親水性リンカーが、前記疎水性鎖と前記光分解性リンカーとの間に配置されていることを特徴とする該光分解性細胞固定化剤。
A photolytic cell immobilization agent for immobilizing predetermined target cells on a substrate, comprising:
A hydrophobic chain capable of interacting with the target cell,
It has a hydrophilic chain that can be arranged in the form of a monolayer on the surface of the substrate, and a hydrophilic linker and a photocleavable linker that connect the hydrophobic chain and the hydrophilic chain,
The photocleavable cell fixing agent, wherein the hydrophilic linker is disposed between the hydrophobic chain and the photocleavable linker.
 前記親水性リンカーが、親水性ポリマーを含む、請求項1に記載の光分解性細胞固定化剤。 The photodegradable cell fixing agent according to claim 1, wherein the hydrophilic linker comprises a hydrophilic polymer.  前記親水性リンカーが、ポリアルキレングリコールを含む、請求項1に記載の光分解性細胞固定化剤。 The photodegradable cell fixing agent according to claim 1, wherein the hydrophilic linker comprises a polyalkylene glycol.  前記親水性リンカーが、以下の部分構造を有する、請求項1に記載の光分解性細胞固定化剤。
Figure JPOXMLDOC01-appb-C000001

(式中、mは、2より大きい自然数である。)
The photocleavable cell fixing agent according to claim 1, wherein the hydrophilic linker has the following partial structure.
Figure JPOXMLDOC01-appb-C000001

(Wherein, m is a natural number greater than 2)
 mが、4~40の自然数である、請求項4に記載の光分解性細胞固定化剤。 The photodegradable cell fixing agent according to claim 4, wherein m is a natural number of 4 to 40.  前記疎水性鎖が、置換基を有していてもよい飽和又は不飽和の炭化水素鎖である、請求項1~5のいずれかに記載の光分解性細胞固定化剤。 The photodegradable cell fixing agent according to any one of claims 1 to 5, wherein the hydrophobic chain is a saturated or unsaturated hydrocarbon chain which may have a substituent.  前記親水性鎖が、親水性ポリマーを含む、請求項1~6のいずれかに記載の光分解性細胞固定化剤。 The photodegradable cell fixing agent according to any one of claims 1 to 6, wherein the hydrophilic chain comprises a hydrophilic polymer.  前記親水性鎖が、ポリアルキレングリコールを含む、請求項1~6のいずれかに記載の光分解性細胞固定化剤。 The photodegradable cell fixing agent according to any one of claims 1 to 6, wherein the hydrophilic chain comprises a polyalkylene glycol.  前記光分解性リンカーが、2-ニトロベンジル骨格、クマリン-4-イルメチル骨格、フェニルカルボニルメチル骨格又は7-ニトロインドリノカルボニル骨格を有する二価の基である、請求項1~8のいずれかに記載の光分解性細胞固定化剤。 The photolyzable linker is a divalent group having a 2-nitrobenzyl skeleton, a coumarin-4-ylmethyl skeleton, a phenylcarbonylmethyl skeleton or a 7-nitroindolinoxycarbonyl skeleton. Photodegradable cell fixing agent as described.  前記親水性鎖及び親水性リンカーがいずれも、ポリエチレングリコールを含む、請求項1~9のいずれかに記載の光分解性細胞固定化剤。 The photocleavable cell fixing agent according to any one of claims 1 to 9, wherein the hydrophilic chain and the hydrophilic linker both include polyethylene glycol.  前記親水性鎖の末端に、前記基材の表面と共有結合により結合し得る置換基を有する、請求項1~10のいずれかに記載の光分解性細胞固定化剤。 The photodegradable cell fixing agent according to any one of claims 1 to 10, which has a substituent which can be covalently bonded to the surface of the substrate at the end of the hydrophilic chain.  以下の構造を有する、請求項1に記載の光分解性細胞固定化剤。
Figure JPOXMLDOC01-appb-C000002


(式中、mは、2~40の自然数であり、nは、45~500の自然数である。)
The photodegradable cell fixing agent according to claim 1, which has the following structure.
Figure JPOXMLDOC01-appb-C000002


(Wherein, m is a natural number of 2 to 40, and n is a natural number of 45 to 500)
 請求項1~12のいずれかに記載の光分解性細胞固定化剤によって修飾された表面を有する、細胞固定化用基材。 A substrate for cell immobilization, which has a surface modified by the photolytic cell immobilization agent according to any one of claims 1 to 12.  前記基材の特定の表面領域のみに光分解性細胞固定化剤を有する、パターン化された表面修飾を有する、請求項13に記載の細胞固定化用基材。 The cell immobilization substrate according to claim 13, having a patterned surface modification having a photolytic cell immobilization agent only on a specific surface area of the substrate.  請求項1~12のいずれかに記載の光分解性細胞固定化剤で基材表面全体を修飾する工程、及び
 光分解性細胞固定化剤による表面修飾が特定の領域のみ維持されるように表面をパターン化する工程であって、基材表面における前記特定の領域以外の領域に光を照射して、光分解性細胞固定化剤における光分解性リンカー部分を切断する、該工程、
を含む細胞固定化用基材の製造方法。
A step of modifying the entire substrate surface with the photolytic cell fixing agent according to any one of claims 1 to 12, and a surface such that the surface modification with the photolytic cell fixing agent is maintained only in a specific region. Patterning the substrate surface by irradiating light to a region other than the specific region on the substrate surface, and cleaving the photodegradable linker moiety in the photodegradable cell fixing agent.
A method for producing a substrate for cell immobilization, comprising
 請求項13又は14に記載の細胞固定化用基材に所定の標的細胞を含む溶液を接触させ、前記細胞固定化用基材に前記標的細胞を固定化する工程、
 前記細胞固定化用基材に光を照射し、前記細胞固定化用基材の表面の光分解性細胞固定化剤における光分解性リンカー部分を切断することで、前記固定化された標的細胞を前記細胞固定化用基材から分離・回収する工程、
を含む、細胞の回収方法。
Allowing a solution containing a predetermined target cell to contact the cell immobilization substrate according to claim 13 or 14, and immobilizing the target cell on the cell immobilization substrate.
The immobilized target cells are obtained by irradiating the substrate for cell immobilization with light and cleaving the photodegradable linker moiety in the photolytic cell immobilization agent on the surface of the substrate for cell immobilization. Separating and recovering from the substrate for cell immobilization,
Cell recovery methods, including:
PCT/JP2018/040853 2017-11-06 2018-11-02 Photodegradable cell immobilization agent Ceased WO2019088258A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019550500A JP7205910B2 (en) 2017-11-06 2018-11-02 Photodegradable cell fixative

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017214107 2017-11-06
JP2017-214107 2017-11-06

Publications (1)

Publication Number Publication Date
WO2019088258A1 true WO2019088258A1 (en) 2019-05-09

Family

ID=66331995

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/040853 Ceased WO2019088258A1 (en) 2017-11-06 2018-11-02 Photodegradable cell immobilization agent

Country Status (2)

Country Link
JP (1) JP7205910B2 (en)
WO (1) WO2019088258A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023077272A (en) * 2021-11-24 2023-06-05 学校法人聖路加国際大学 Methods for evaluating cell characteristics

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008125952A (en) * 2006-11-24 2008-06-05 National Institute For Materials Science Composite cross-linked body
WO2016158327A1 (en) * 2015-03-30 2016-10-06 国立大学法人 東京大学 Compound for fixing lipid membrane-containing composition, base material modified by compound, method for patterning lipid membrane-containing composition on base material, and method for isolating lipid membrane-containing composition on base material

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008125952A (en) * 2006-11-24 2008-06-05 National Institute For Materials Science Composite cross-linked body
WO2016158327A1 (en) * 2015-03-30 2016-10-06 国立大学法人 東京大学 Compound for fixing lipid membrane-containing composition, base material modified by compound, method for patterning lipid membrane-containing composition on base material, and method for isolating lipid membrane-containing composition on base material

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
NAGAMUNE, TERUYUKI: "Development of microchip for identifying and separating tumor cells circulating in blood", 2015 RESEARCH PERFORMANCE REPORT ON SCIENTIFIC RESEARCH FUND- RAISING BUSINESS, 10 May 2017 (2017-05-10) *
YAMAGUCHI, S. ET AL.: "Photocontrollable dynamic micropatterning of non-adherent mammalian cells using a photocleavable poly (ethylene glycol) lipid", ANGEW. CHEM. INT. ED., vol. 51, 2012, pages 128 - 131, XP055602106 *
YAMAGUCHI, SATOSHI ET AL.: "35.1 Development of photoresponsive cell -fixing agent, aiming at cell operation", LECTURE ABSTRACTS OF THE 28TH BIO AND POLYMER SYMPOSIUM, 20 July 2018 (2018-07-20), pages 155 - 156 *
YAMAHIRA, S. ET AL.: "Collagen surfaces modified with photo-cleavable polyethylene glycol-lipid support versatile single- cell arrays of both non- adherent and adherent cells", MACROMOL. BIOSCI., vol. 14, 2014, pages 1670 - 1676, XP55612997 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023077272A (en) * 2021-11-24 2023-06-05 学校法人聖路加国際大学 Methods for evaluating cell characteristics

Also Published As

Publication number Publication date
JPWO2019088258A1 (en) 2020-11-26
JP7205910B2 (en) 2023-01-17

Similar Documents

Publication Publication Date Title
US20140099695A1 (en) Cell-adhering light-controllable substrate
JP4630817B2 (en) Substance immobilizing agent, substance immobilizing method using the same, and substance immobilizing substrate using the same
Elahipanah et al. General dialdehyde click chemistry for amine bioconjugation
US20230152306A1 (en) Nanoparticles for sensing use and production method for same
CN103076312B (en) Cell fluorescent labeling method
WO2016140369A1 (en) Cellulose three-dimensional structure and production method therefor
JP6901714B2 (en) A compound for immobilizing a lipid film-containing material, a base material modified with the compound, a method for patterning the lipid film-containing material on the base material, and a method for isolating the lipid film-containing material on the base material.
CN112980786B (en) T cell and nanoparticle connection method based on click chemistry
WO2019088258A1 (en) Photodegradable cell immobilization agent
CN116803995B (en) A class of aminoamide lipid compounds and preparation methods and applications thereof
CN112375562A (en) Cysteine-polyamine-morpholine-modified quantum dot lysosome targeted fluorescent probe and preparation method and application thereof
CA2914448A1 (en) Compounds for promoting liposomal and cellular adhesion and compositions and methods of use thereof
JP2006524680A (en) Charged initiator polymers and methods of use
CN115645530A (en) Double-activation photodynamic immune prodrug based on hemicyanine and IDO inhibitor and preparation method and application thereof
US8728520B2 (en) Cross-linked alginate-polyalkylene glycol polymer coatings for encapsulation and methods of making the same
US20200231919A1 (en) Transparent disc-shaped microparticles coated with polydopamine
CN104610912A (en) Photodegradable magnetic nanometer material, photodegradable magnetic nanometer biological probe and preparation methods thereof
WO2019230441A1 (en) Photoresponsive cell fixing agent
JP2014073092A (en) Cell collection device, apparatus, and method
CN113293137B (en) Modification method of dendritic cells based on cell membrane surface modification technology and application of modification method
JP2023165489A (en) Method for manufacturing substrate for cell immobilization
JP5099074B2 (en) Adsorption carrier having selective adsorption region of target molecule and method for producing the same
JP7752415B2 (en) Biomaterial immobilization materials
WO2025134839A1 (en) Surface-modified substrate for culturing and recovering cell clusters
US20130281656A1 (en) Methods for labeling a substrate having a plurality of thiol groups attached thereto

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18874529

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2019550500

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18874529

Country of ref document: EP

Kind code of ref document: A1